MeSH term
Frequency | Condition_Probility | *Cleavage Stage, Ovum | 2 | 1.0 |
Embryo Transfer/*standards | 2 | 1.0 |
Female | 511 | 0.0 |
Humans | 2395 | 1.0 |
Meta-Analysis | 2 | 1.0 |
Pregnancy | 267 | 4.0 |
Pregnancy Outcome | 4 | 1.0 |
Pregnancy Rate | 2 | 1.0 |
Pregnancy, Multiple | 4 | 2.0 |
Randomized Controlled Trials | 3 | 0.0 |
Review Literature | 2 | 1.0 |
Animals | 986 | 1.0 |
Oligonucleotide Array Sequence Analysis | 5 | 0.0 |
Cell Culture Techniques | 3 | 0.0 |
Motor Neurons/*physiology | 4 | 7.0 |
Stem Cells/*physiology | 2 | 3.0 |
Adolescent | 32 | 0.0 |
Adult | 151 | 0.0 |
Aged | 57 | 0.0 |
Child | 16 | 0.0 |
Child, Preschool | 11 | 0.0 |
Infant | 9 | 0.0 |
Male | 224 | 0.0 |
Middle Aged | 94 | 0.0 |
Indoles/*therapeutic use | 2 | 1.0 |
Risk | 4 | 0.0 |
Time Factors | 71 | 0.0 |
*Amino Acid Motifs | 2 | 7.0 |
CHO Cells | 32 | 1.0 |
Cricetulus | 7 | 1.0 |
Drug Evaluation, Preclinical | 2 | 1.0 |
*Genes, Reporter | 2 | 4.0 |
Genetic Vectors | 34 | 2.0 |
Half-Life | 11 | 1.0 |
Hamsters | 58 | 1.0 |
Hela Cells | 363 | 6.0 |
Proteins/metabolism | 8 | 0.0 |
RNA Stability | 3 | 4.0 |
RNA, Messenger/metabolism | 92 | 2.0 |
Recombinant Fusion Proteins/analysis/genetics | 3 | 16.0 |
*Regulatory Sequences, Ribonucleic Acid | 3 | 13.0 |
Research Support, Non-U.S. Gov't | 1567 | 1.0 |
Terminology | 5 | 3.0 |
*Transcription, Genetic | 258 | 13.0 |
Transfection | 532 | 4.0 |
*Cell Transformation, Neoplastic | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 967 | 1.0 |
Diagnosis, Differential | 11 | 0.0 |
Antineoplastic Agents/*pharmacology | 7 | 0.0 |
Cell Cycle/drug effects | 3 | 0.0 |
DNA Fragmentation | 3 | 0.0 |
DNA-Binding Proteins/biosynthesis/genetics | 3 | 4.0 |
Dose-Response Relationship, Drug | 41 | 0.0 |
Protein p53/*metabolism | 10 | 1.0 |
Proto-Oncogene Proteins c-bcl-2/metabolism | 4 | 0.0 |
Transcription Factors/biosynthesis/genetics | 2 | 2.0 |
English Abstract | 92 | 0.0 |
Base Sequence/genetics | 20 | 5.0 |
Binding Sites/genetics/physiology | 2 | 11.0 |
Cell Line | 494 | 2.0 |
Conserved Sequence | 34 | 2.0 |
Electrophoretic Mobility Shift Assay/methods | 3 | 14.0 |
Evolution, Molecular | 11 | 1.0 |
Ligases/*genetics | 2 | 1.0 |
Molecular Sequence Data | 1237 | 3.0 |
Pan troglodytes | 3 | 2.0 |
Promoter Regions (Genetics)/*genetics/*physiology | 2 | 50.0 |
Sequence Analysis, DNA/methods | 3 | 3.0 |
Transcription Factors/metabolism | 177 | 12.0 |
Tumor Cells, Cultured | 478 | 2.0 |
*Tumor Suppressor Proteins | 10 | 0.0 |
*Ubiquitin-Protein Ligases | 4 | 0.0 |
Amino Acid Motifs | 17 | 1.0 |
Base Sequence | 1275 | 4.0 |
Binding Sites | 523 | 7.0 |
Binding, Competitive | 59 | 3.0 |
Blotting, Northern | 68 | 1.0 |
Blotting, Western | 85 | 1.0 |
COS Cells | 47 | 1.0 |
Cell Differentiation | 37 | 1.0 |
Cell Nucleus/metabolism | 121 | 6.0 |
Cells, Cultured | 233 | 1.0 |
DNA/*metabolism | 34 | 8.0 |
DNA-Binding Proteins/*metabolism | 203 | 9.0 |
Drosophila | 50 | 16.0 |
Endothelium, Vascular/*metabolism | 6 | 2.0 |
*Enhancer Elements (Genetics) | 39 | 14.0 |
Fibroblasts/metabolism | 28 | 3.0 |
Genes, Reporter | 181 | 9.0 |
Immunoblotting | 24 | 1.0 |
Mice | 457 | 1.0 |
Muscle, Smooth/*metabolism | 2 | 8.0 |
Mutation | 148 | 1.0 |
Oligonucleotides/metabolism | 14 | 19.0 |
Plasmids/metabolism | 56 | 4.0 |
Plicamycin/*analogs & derivatives/pharmacology | 6 | 85.0 |
Protein Binding | 297 | 3.0 |
Rats | 210 | 1.0 |
Transcription Factor, Sp1/*metabolism | 341 | 93.0 |
Transcription Factors/*metabolism | 231 | 14.0 |
5' Untranslated Regions | 11 | 7.0 |
Amino Acid Sequence | 254 | 1.0 |
Carrier Proteins/*genetics | 22 | 1.0 |
Comparative Study | 264 | 0.0 |
DNA, Complementary/chemistry | 3 | 1.0 |
Membrane Proteins/*genetics | 27 | 3.0 |
Mice, Inbred C3H | 4 | 0.0 |
*Phospholipid Transfer Proteins | 4 | 2.0 |
Promoter Regions (Genetics) | 495 | 11.0 |
Regulatory Sequences, Nucleic Acid | 115 | 19.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 153 | 1.0 |
Reverse Transcriptase Polymerase Chain Reaction | 75 | 1.0 |
Sequence Alignment | 81 | 1.0 |
Sequence Analysis, DNA | 107 | 3.0 |
Circular Dichroism | 8 | 1.0 |
Glycine/chemistry | 2 | 6.0 |
Ligands | 18 | 0.0 |
Protein Conformation | 16 | 0.0 |
*Protein Folding | 2 | 1.0 |
Spectrophotometry, Ultraviolet | 2 | 1.0 |
Transcription Factor, Sp1/*chemistry | 5 | 83.0 |
Zinc Fingers | 53 | 10.0 |
Cell Division | 26 | 0.0 |
Chromatin/metabolism | 28 | 9.0 |
DNA-Binding Proteins/metabolism | 168 | 8.0 |
Enzyme Activation | 17 | 0.0 |
Enzyme Inhibitors/pharmacology | 42 | 1.0 |
Gene Expression Regulation | 175 | 5.0 |
*Gene Silencing | 7 | 3.0 |
Histone Deacetylases/antagonists & inhibitors/*metabolism | 3 | 18.0 |
Histones/metabolism | 10 | 4.0 |
Hydroxamic Acids/pharmacology | 18 | 11.0 |
Macromolecular Substances | 45 | 2.0 |
Multiprotein Complexes | 2 | 4.0 |
Precipitin Tests | 52 | 1.0 |
RNA Polymerase II/metabolism | 7 | 6.0 |
Repressor Proteins/*metabolism | 10 | 5.0 |
Transcription Factor, Sp1/metabolism | 259 | 76.0 |
Alkaline Phosphatase/pharmacology | 2 | 22.0 |
Endometrium/*metabolism | 4 | 4.0 |
Phosphorylation/drug effects | 4 | 0.0 |
Progesterone/pharmacology | 3 | 2.0 |
Promoter Regions (Genetics)/*genetics | 159 | 19.0 |
Protein Processing, Post-Translational/drug effects | 2 | 1.0 |
Protein Structure, Tertiary | 48 | 1.0 |
Recombinant Fusion Proteins/physiology | 6 | 2.0 |
Stromal Cells/metabolism | 3 | 3.0 |
*Trans-Activation (Genetics) | 90 | 11.0 |
Transcription Factor, Sp1/*physiology | 83 | 95.0 |
Cell Differentiation/drug effects | 10 | 0.0 |
Extracellular Matrix Proteins/*genetics | 3 | 3.0 |
Gene Expression Regulation/drug effects | 45 | 5.0 |
Luciferases/genetics/metabolism | 45 | 21.0 |
RNA, Messenger/drug effects/genetics/metabolism | 5 | 5.0 |
Recombinant Fusion Proteins/genetics/metabolism | 48 | 4.0 |
Tretinoin/pharmacology | 5 | 1.0 |
Anti-Inflammatory Agents, Non-Steroidal/*pharmacology | 3 | 2.0 |
DNA/metabolism | 110 | 7.0 |
DNA Mutational Analysis | 62 | 1.0 |
Flavonoids/pharmacology | 10 | 3.0 |
Gene Deletion | 62 | 3.0 |
Phosphorylation | 65 | 0.0 |
Signal Transduction | 43 | 0.0 |
Transcription Factor, Sp1/*antagonists & inhibitors | 2 | 100.0 |
Acetylation | 16 | 3.0 |
DNA-Binding Proteins/genetics/metabolism | 37 | 7.0 |
Histone Deacetylases/metabolism | 5 | 6.0 |
Histones/*metabolism | 10 | 7.0 |
RNA, Messenger/biosynthesis | 28 | 1.0 |
Response Elements | 28 | 12.0 |
Superoxide Dismutase/biosynthesis/*genetics | 2 | 16.0 |
Transcription Factors/genetics/metabolism | 41 | 9.0 |
Carcinoma, Squamous Cell | 3 | 1.0 |
DNA Primers | 89 | 1.0 |
Epidermal Growth Factor/*pharmacology | 8 | 0.0 |
Gene Expression Regulation, Neoplastic/drug effects/*physiology | 4 | 16.0 |
Mitogen-Activated Protein Kinases/*metabolism | 9 | 1.0 |
Polymerase Chain Reaction | 104 | 0.0 |
Transforming Growth Factor alpha/pharmacology | 2 | 2.0 |
Tumor Necrosis Factor-alpha/pharmacology | 9 | 0.0 |
Adenocarcinoma | 9 | 7.0 |
Breast Neoplasms | 8 | 2.0 |
Cell Cycle Proteins/metabolism | 5 | 1.0 |
Cyclin-Dependent Kinases/*antagonists & inhibitors | 5 | 3.0 |
*DNA-Binding Proteins | 52 | 3.0 |
Enzyme Inhibitors | 3 | 3.0 |
Glutathione Transferase/genetics | 3 | 1.0 |
Plasmids | 73 | 5.0 |
*Promoter Regions (Genetics) | 542 | 23.0 |
Recombinant Fusion Proteins/metabolism | 37 | 2.0 |
Recombinant Proteins/metabolism | 47 | 1.0 |
Sequence Deletion | 114 | 5.0 |
TATA Box | 83 | 26.0 |
Transcription, Genetic | 427 | 7.0 |
Tumor Suppressor Proteins/*genetics | 2 | 1.0 |
Endothelium, Vascular/cytology/*metabolism | 6 | 3.0 |
Gene Transfer Techniques | 4 | 0.0 |
Signal Transduction/physiology | 8 | 0.0 |
Collagen/metabolism | 2 | 0.0 |
Endothelial Growth Factors/*metabolism | 2 | 0.0 |
Green Fluorescent Proteins | 6 | 0.0 |
Hydrogen Peroxide/*pharmacology | 2 | 3.0 |
Keratinocytes/*metabolism | 6 | 6.0 |
Luciferases/metabolism | 70 | 11.0 |
Lymphokines/*metabolism | 2 | 0.0 |
Mice, Inbred BALB C | 18 | 0.0 |
Microscopy, Fluorescence | 6 | 0.0 |
Neovascularization, Pathologic | 2 | 0.0 |
Oxidation-Reduction | 15 | 1.0 |
Phosphotyrosine/metabolism | 2 | 0.0 |
Ribonucleases/metabolism | 7 | 5.0 |
Trans-Activation (Genetics) | 141 | 8.0 |
Vascular Endothelial Growth Factor A | 19 | 0.0 |
Vascular Endothelial Growth Factors | 19 | 0.0 |
Cell Hypoxia/physiology | 3 | 4.0 |
DNA-Binding Proteins/*physiology | 56 | 11.0 |
Gene Expression Regulation, Neoplastic | 33 | 1.0 |
Genes, MDR/*genetics | 2 | 6.0 |
Nuclear Proteins/*physiology | 11 | 7.0 |
P-Glycoprotein/biosynthesis/genetics | 2 | 22.0 |
*Transcription Factors | 46 | 2.0 |
Binding Sites/physiology | 8 | 4.0 |
CCAAT-Binding Factor/*metabolism | 5 | 31.0 |
Cell Nucleus/chemistry/metabolism | 2 | 12.0 |
Cyclic AMP/*pharmacology | 4 | 7.0 |
Enhancer Elements (Genetics) | 37 | 9.0 |
GC Rich Sequence | 9 | 42.0 |
Nuclear Proteins/metabolism | 86 | 10.0 |
Promoter Regions (Genetics)/physiology | 14 | 8.0 |
Rats, Wistar | 9 | 0.0 |
Trans-Activation (Genetics)/drug effects/*physiology | 3 | 27.0 |
5' Flanking Region/genetics | 18 | 20.0 |
Binding Sites/genetics | 123 | 13.0 |
DNA/chemistry/genetics/metabolism | 12 | 26.0 |
Electrophoretic Mobility Shift Assay | 72 | 16.0 |
Oligonucleotides/genetics/metabolism | 12 | 36.0 |
Promoter Regions (Genetics)/genetics | 123 | 11.0 |
Protein Precursors/*genetics | 4 | 3.0 |
Sequence Homology, Nucleic Acid | 147 | 5.0 |
Transcription Factor, Sp1/metabolism/*physiology | 15 | 100.0 |
5' Flanking Region/*genetics | 6 | 22.0 |
*Cell Cycle Proteins | 33 | 2.0 |
Cloning, Molecular | 287 | 3.0 |
DNA-Binding Proteins/genetics | 28 | 3.0 |
Mutagenesis | 45 | 4.0 |
Sequence Analysis | 12 | 3.0 |
Transcription Factor, Sp1/*genetics | 40 | 95.0 |
Transcription Factors/genetics | 27 | 3.0 |
Transcription Initiation Site | 43 | 32.0 |
DNA Footprinting | 89 | 31.0 |
Deoxyribonuclease I/metabolism | 34 | 25.0 |
Electrophoresis, Polyacrylamide Gel | 65 | 1.0 |
Promoter Regions (Genetics)/*immunology | 7 | 16.0 |
Breast Neoplasms/*metabolism | 3 | 1.0 |
Cell Cycle | 17 | 1.0 |
Estrogens/*metabolism | 4 | 7.0 |
*Gene Expression Regulation, Neoplastic | 31 | 2.0 |
Immunohistochemistry | 35 | 0.0 |
RNA, Messenger/*metabolism | 6 | 0.0 |
Cercopithecus aethiops | 28 | 2.0 |
Herpes Simplex/virology | 2 | 28.0 |
Immediate-Early Proteins/genetics/*metabolism | 3 | 5.0 |
Vero Cells | 7 | 3.0 |
Acetyltransferases/metabolism | 3 | 4.0 |
Cell Transformation, Neoplastic | 3 | 0.0 |
CpG Islands | 15 | 5.0 |
Cyclins/genetics/*metabolism | 2 | 2.0 |
DNA/genetics/metabolism | 57 | 15.0 |
*DNA Methylation | 14 | 2.0 |
Trans-Activators/metabolism | 34 | 3.0 |
Algorithms | 5 | 1.0 |
Bone and Bones/*enzymology | 2 | 40.0 |
Databases, Genetic | 2 | 2.0 |
Genes, Regulator/genetics | 8 | 17.0 |
Genome, Human | 14 | 3.0 |
Linear Models | 2 | 0.0 |
Models, Genetic | 60 | 3.0 |
RNA, Messenger/*biosynthesis | 3 | 1.0 |
Sensitivity and Specificity | 15 | 0.0 |
Transcription, Genetic/genetics | 22 | 6.0 |
DNA-Binding Proteins/*genetics/metabolism | 21 | 5.0 |
*Gene Expression Regulation | 168 | 8.0 |
Mutagenesis, Site-Directed | 174 | 5.0 |
Transcription Factor, Sp1/*genetics/metabolism | 19 | 90.0 |
Insulin-Like Growth Factor I/*physiology | 2 | 5.0 |
Swine | 12 | 0.0 |
Exons/genetics | 35 | 2.0 |
Receptors, Glucocorticoid/*genetics/metabolism | 2 | 18.0 |
Tissue Distribution | 40 | 1.0 |
*Immediate-Early Proteins | 51 | 21.0 |
DNA-Binding Proteins/chemistry/genetics/*metabolism | 5 | 2.0 |
Drosophila melanogaster | 23 | 20.0 |
Recombinant Fusion Proteins/chemistry/metabolism | 4 | 2.0 |
Response Elements/genetics | 28 | 16.0 |
Transcription Factor, Sp1/genetics/*metabolism | 72 | 93.0 |
Transcription Factors/chemistry/genetics/*metabolism | 11 | 7.0 |
Two-Hybrid System Techniques | 8 | 0.0 |
Apoptosis | 12 | 0.0 |
*Chromosomes, Human, Pair 14 | 4 | 2.0 |
*Chromosomes, Human, Pair 18 | 4 | 2.0 |
Cyclic AMP/metabolism | 5 | 0.0 |
NF-kappa B/*metabolism | 30 | 5.0 |
Proto-Oncogene Proteins c-bcl-2/*metabolism | 2 | 0.0 |
*Translocation, Genetic | 3 | 0.0 |
Tumor Necrosis Factor-alpha/metabolism | 4 | 0.0 |
Ultraviolet Rays | 14 | 2.0 |
Cell Lineage | 4 | 0.0 |
DNA, Complementary/metabolism | 15 | 1.0 |
Models, Biological | 24 | 0.0 |
Carrier Proteins/metabolism | 6 | 0.0 |
Angiotensinogen/*genetics/metabolism | 2 | 40.0 |
Carcinoma, Hepatocellular/genetics | 2 | 7.0 |
DNA Primers/chemistry | 23 | 1.0 |
Liver Neoplasms/*genetics | 2 | 1.0 |
Alternative Splicing | 18 | 1.0 |
DNA Methylation | 27 | 3.0 |
*Drosophila Proteins | 10 | 0.0 |
Macrophages/*metabolism | 5 | 2.0 |
Membrane Glycoproteins/*genetics | 13 | 3.0 |
Monocytes/*metabolism | 3 | 0.0 |
NF-kappa B/metabolism | 40 | 5.0 |
RNA, Messenger/analysis | 32 | 0.0 |
Receptors, Cell Surface/*genetics | 9 | 3.0 |
Gene Expression Regulation, Enzymologic/*physiology | 7 | 8.0 |
Luciferases/genetics | 54 | 15.0 |
Papillomavirus, Human/*physiology | 3 | 15.0 |
Telomerase/*genetics | 3 | 10.0 |
Capsid/*metabolism | 2 | 16.0 |
*Capsid Proteins | 5 | 4.0 |
DNA, Viral/genetics/metabolism | 7 | 23.0 |
*Gene Expression Regulation, Viral | 35 | 11.0 |
Simian virus 40/metabolism | 2 | 22.0 |
Disease Progression | 8 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 14 | 0.0 |
*MAP Kinase Signaling System | 4 | 3.0 |
Mitogen-Activated Protein Kinases/metabolism | 8 | 0.0 |
Oxygen/*metabolism | 3 | 2.0 |
Protein-Serine-Threonine Kinases/metabolism | 13 | 1.0 |
Up-Regulation | 43 | 1.0 |
p38 Mitogen-Activated Protein Kinases | 6 | 0.0 |
5' Flanking Region | 15 | 26.0 |
*Gene Expression | 12 | 1.0 |
Proto-Oncogene Proteins/*metabolism | 17 | 1.0 |
Gene Library | 21 | 1.0 |
Multigene Family | 20 | 2.0 |
Sequence Homology, Amino Acid | 76 | 0.0 |
Protein-Tyrosine Kinase/*genetics | 6 | 2.0 |
Membrane Proteins/chemistry/*genetics | 2 | 3.0 |
X Chromosome | 4 | 0.0 |
Cytoskeletal Proteins/*genetics | 3 | 2.0 |
DNA-Binding Proteins/analysis/genetics/metabolism | 3 | 37.0 |
Gene Expression Regulation/physiology | 9 | 3.0 |
*Oncogene Proteins | 2 | 3.0 |
Promoter Regions (Genetics)/*physiology | 18 | 20.0 |
Utrophin | 4 | 15.0 |
Brain/metabolism | 15 | 2.0 |
Cell Death | 3 | 0.0 |
DNA-Binding Proteins/chemistry/*metabolism | 8 | 4.0 |
Down-Regulation | 42 | 2.0 |
Mice, Transgenic | 33 | 1.0 |
Neurons/physiology | 2 | 1.0 |
*TATA-Binding Protein Associated Factors | 9 | 9.0 |
*Transcription Factor TFIID | 6 | 11.0 |
Transcription Factor, Sp1/chemistry/*metabolism | 8 | 100.0 |
Transcription Factors/chemistry/*metabolism | 9 | 6.0 |
Trinucleotide Repeat Expansion | 2 | 5.0 |
3T3 Cells | 75 | 3.0 |
Chromosome Mapping | 73 | 0.0 |
DNA/chemistry/metabolism | 13 | 15.0 |
Gene Expression | 84 | 1.0 |
Pituitary Gland/*metabolism | 2 | 5.0 |
Pituitary Neoplasms | 4 | 22.0 |
Transcription Factor, Sp1/genetics/physiology | 3 | 75.0 |
Transcription Factors/genetics/*metabolism/physiology | 3 | 23.0 |
*Zinc Fingers | 27 | 13.0 |
Endothelial Growth Factors/*genetics/metabolism | 3 | 6.0 |
Gene Expression Regulation/*drug effects | 29 | 4.0 |
Lymphokines/*genetics/metabolism | 3 | 6.0 |
Recombinant Fusion Proteins/genetics | 14 | 8.0 |
Tretinoin/*pharmacology | 10 | 3.0 |
5' Flanking Region/*physiology | 2 | 66.0 |
DNA | 80 | 7.0 |
Proteins/*genetics | 22 | 1.0 |
Transcription Factor AP-1/metabolism | 17 | 6.0 |
Transcription Factor TFIID | 28 | 16.0 |
Transcription Factors, TFII/metabolism | 5 | 13.0 |
Chromosome Banding | 2 | 0.0 |
Chromosomes, Human, Pair 2/*genetics | 2 | 1.0 |
Drug Resistance/*genetics | 2 | 4.0 |
*Gene Expression Regulation, Enzymologic | 55 | 11.0 |
In Situ Hybridization, Fluorescence | 19 | 0.0 |
Karyotyping | 9 | 0.0 |
Protein Subunits | 8 | 2.0 |
RNA, Messenger/genetics/metabolism | 43 | 1.0 |
Staining and Labeling | 5 | 0.0 |
Transcription, Genetic/*genetics | 20 | 10.0 |
Antigens, CD/genetics | 2 | 1.0 |
Deoxyribonuclease I | 52 | 36.0 |
Exons | 146 | 3.0 |
Gene Expression Regulation/*physiology | 19 | 5.0 |
Genomic Library | 37 | 9.0 |
*Membrane Proteins | 7 | 0.0 |
*Receptors, Lipoprotein | 2 | 1.0 |
Restriction Mapping | 113 | 5.0 |
Antiviral Agents/*pharmacology | 4 | 2.0 |
Microbial Sensitivity Tests | 2 | 0.0 |
*Protein-Serine-Threonine Kinases | 6 | 0.0 |
Proto-Oncogene Proteins/metabolism | 19 | 1.0 |
Ribosomal Protein S6 Kinases/metabolism | 2 | 2.0 |
Sesquiterpenes/*pharmacology | 2 | 5.0 |
Virus Replication/drug effects | 3 | 1.0 |
CCAAT-Binding Factor/metabolism | 5 | 27.0 |
Cell Cycle Proteins/*genetics | 3 | 1.0 |
Consensus Sequence | 76 | 10.0 |
Protein p53/metabolism | 9 | 1.0 |
*Response Elements | 7 | 10.0 |
Dihydrotestosterone/pharmacology | 2 | 2.0 |
Enzyme Inhibitors/metabolism | 3 | 1.0 |
In Vitro | 46 | 0.0 |
*MAP Kinase Kinase Kinase 1 | 3 | 2.0 |
Point Mutation | 40 | 1.0 |
Protein-Serine-Threonine Kinases/*metabolism | 6 | 0.0 |
Receptors, Androgen/genetics/*metabolism | 2 | 4.0 |
Trans-Activators/genetics/metabolism | 8 | 4.0 |
Tumor Necrosis Factor-alpha/genetics/metabolism | 3 | 5.0 |
Incidence | 3 | 0.0 |
Regression Analysis | 7 | 0.0 |
Retrospective Studies | 15 | 0.0 |
Risk Factors | 12 | 0.0 |
Carcinoma, Hepatocellular/pathology | 2 | 4.0 |
DNA-Binding Proteins | 6 | 6.0 |
Plicamycin/pharmacology | 14 | 87.0 |
Protein Synthesis Inhibitors/pharmacology | 8 | 2.0 |
Alleles | 16 | 0.0 |
Carcinoma, Hepatocellular/metabolism | 7 | 7.0 |
*CpG Islands | 4 | 5.0 |
DNA-Binding Proteins/*chemistry/metabolism | 2 | 2.0 |
Methylation | 27 | 4.0 |
*Exons | 11 | 3.0 |
Nitric-Oxide Synthase/*genetics | 4 | 4.0 |
RNA, Messenger/genetics | 69 | 2.0 |
Transcription Factors/*physiology | 72 | 15.0 |
Glutathione Transferase/metabolism | 18 | 2.0 |
Peptides/chemistry | 3 | 0.0 |
Protein Isoforms | 12 | 1.0 |
Transcription Factors/*chemistry/metabolism | 2 | 4.0 |
Catalysis | 7 | 0.0 |
Gene Expression Regulation, Enzymologic | 44 | 5.0 |
Genes, Dominant | 6 | 0.0 |
Protein Kinase C/*metabolism | 5 | 1.0 |
Proto-Oncogene Proteins c-fos/metabolism | 3 | 2.0 |
Proto-Oncogene Proteins c-jun/*metabolism | 11 | 14.0 |
*Signal Transduction | 9 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 56 | 3.0 |
*Mitochondrial Proteins | 3 | 1.0 |
Nuclear Proteins/*genetics/metabolism | 8 | 6.0 |
Polymerase Chain Reaction/methods | 13 | 1.0 |
Trans-Activators/genetics/pharmacology | 2 | 33.0 |
Transcription Factors/*genetics/metabolism | 23 | 6.0 |
Caco-2 Cells | 13 | 3.0 |
Carrier Proteins/*genetics/metabolism | 7 | 2.0 |
Membrane Glycoproteins/*genetics/metabolism | 2 | 2.0 |
Bone Neoplasms | 2 | 9.0 |
Carcinoma, Hepatocellular | 20 | 6.0 |
Liver Neoplasms | 18 | 6.0 |
Osteosarcoma | 4 | 4.0 |
Trans-Activation (Genetics)/*drug effects | 9 | 9.0 |
Transforming Growth Factor beta/*pharmacology | 11 | 2.0 |
Biological Markers | 5 | 0.0 |
Carcinoma/pathology | 2 | 4.0 |
Cell Division/genetics | 4 | 1.0 |
DNA, Complementary/genetics | 28 | 1.0 |
DNA-Binding Proteins/genetics/*physiology | 7 | 3.0 |
Gene Expression Profiling | 2 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 2 | 0.0 |
Mitogen-Activated Protein Kinases/physiology | 3 | 2.0 |
Neoplasm Proteins/biosynthesis/genetics | 6 | 4.0 |
Transcription Factors/genetics/*physiology | 12 | 6.0 |
Helix-Loop-Helix Motifs | 6 | 2.0 |
*Nuclear Proteins | 19 | 1.0 |
Oncogene Proteins/*genetics | 3 | 2.0 |
Transcription Factors/*genetics/*metabolism | 9 | 6.0 |
3',5'-Cyclic-GMP Phosphodiesterase/*genetics | 3 | 18.0 |
Homeodomain Proteins/*metabolism | 2 | 1.0 |
*Phosphoric Diester Hydrolases | 2 | 7.0 |
Rods (Retina)/*enzymology | 2 | 25.0 |
TATA-Box Binding Protein | 24 | 7.0 |
Trans-Activators/*metabolism | 32 | 3.0 |
Transcription Factor TFIIB | 6 | 7.0 |
Xenopus | 4 | 0.0 |
Arteriosclerosis/etiology | 3 | 4.0 |
NF-kappa B/physiology | 6 | 6.0 |
*Oxidative Stress | 3 | 1.0 |
Transcription Factor, Sp1/physiology | 30 | 78.0 |
Gene Expression Regulation/*immunology | 4 | 3.0 |
Protein Binding/genetics/immunology | 3 | 3.0 |
Trans-Activators/metabolism/physiology | 2 | 18.0 |
U937 Cells | 18 | 4.0 |
Cosmids | 6 | 1.0 |
DNA, Complementary/analysis | 7 | 2.0 |
Gene Amplification | 5 | 0.0 |
Kidney/chemistry | 2 | 4.0 |
Protein Biosynthesis | 28 | 2.0 |
Sodium Channels/chemistry/*genetics | 2 | 18.0 |
Multienzyme Complexes/*genetics | 6 | 8.0 |
Transcription Factor, Sp1/genetics/metabolism | 32 | 96.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/metabolism | 10 | 7.0 |
Forskolin/pharmacology | 8 | 2.0 |
Serine/metabolism | 2 | 0.0 |
Intracellular Fluid | 2 | 8.0 |
*Membrane Glycoproteins | 8 | 0.0 |
Neutralization Tests | 2 | 0.0 |
*Trans-Activators | 12 | 1.0 |
Transcription Factor, Sp1/*immunology | 2 | 100.0 |
*Viral Envelope Proteins | 5 | 11.0 |
Macrophages/metabolism | 2 | 0.0 |
Organ Specificity | 38 | 2.0 |
Transcription Factor, Sp1/*metabolism/physiology | 2 | 100.0 |
Transcription, Genetic/physiology | 15 | 8.0 |
5' Untranslated Regions/genetics | 8 | 6.0 |
DNA-Binding Proteins/*genetics | 42 | 2.0 |
*Pol1 Transcription Initiation Complex Proteins | 2 | 10.0 |
Transcription Factors/*genetics | 42 | 2.0 |
Clone Cells | 4 | 0.0 |
Cysteine Endopeptidases/metabolism | 2 | 0.0 |
G1 Phase | 8 | 2.0 |
Kinetics | 40 | 0.0 |
Multienzyme Complexes/metabolism | 2 | 1.0 |
Proteasome Endopeptidase Complex | 2 | 0.0 |
Receptor, Epidermal Growth Factor/metabolism | 4 | 0.0 |
Transcription Factor, Sp1/genetics/immunology/*metabolism | 2 | 100.0 |
Tumor Suppressor Proteins/metabolism | 2 | 1.0 |
Adrenal Cortex/metabolism | 3 | 16.0 |
Aging/*metabolism | 2 | 0.0 |
Immunoenzyme Techniques | 41 | 1.0 |
Infant, Newborn | 30 | 0.0 |
Pancreas/metabolism | 2 | 2.0 |
Connexins/*genetics | 3 | 1.0 |
Cell Line, Tumor | 71 | 2.0 |
Fatty Acids/*pharmacology | 2 | 7.0 |
Plasmids/genetics | 17 | 4.0 |
Promoter Regions (Genetics)/drug effects/*genetics | 5 | 27.0 |
Cell Division/physiology | 5 | 0.0 |
DNA-Binding Proteins/physiology | 24 | 8.0 |
RNA, Messenger/biosynthesis/genetics | 11 | 1.0 |
Brain/blood supply/*physiology | 2 | 66.0 |
Brain Mapping | 3 | 2.0 |
*Cluster Analysis | 2 | 28.0 |
Image Processing, Computer-Assisted/*methods | 2 | 8.0 |
*Magnetic Resonance Imaging | 2 | 1.0 |
Models, Neurological | 2 | 1.0 |
Neural Networks (Computer) | 2 | 8.0 |
Oxygen/blood | 2 | 1.0 |
Principal Component Analysis/*methods | 2 | 66.0 |
ROC Curve | 4 | 2.0 |
Jurkat Cells | 35 | 2.0 |
Response Elements/immunology | 2 | 12.0 |
Transcription Factor, Sp1/genetics/metabolism/physiology | 2 | 100.0 |
Cattle | 45 | 1.0 |
Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors/metabolism | 3 | 12.0 |
Down-Regulation/drug effects/physiology | 2 | 5.0 |
Lipopolysaccharides/pharmacology | 10 | 1.0 |
Nitric Oxide Donors/pharmacology | 2 | 3.0 |
Promoter Regions (Genetics)/drug effects/physiology | 4 | 12.0 |
Protein Binding/drug effects/physiology | 2 | 5.0 |
Transcription Factor, Sp1/antagonists & inhibitors/*metabolism | 2 | 100.0 |
Cell Hypoxia | 2 | 1.0 |
*Genome, Human | 6 | 2.0 |
Lung/cytology | 3 | 5.0 |
Bone Density/*genetics | 3 | 2.0 |
Collagen/*genetics | 23 | 5.0 |
*Collagen Type I | 3 | 14.0 |
Linkage Disequilibrium | 4 | 0.0 |
Oligodeoxyribonucleotides/genetics/metabolism | 4 | 28.0 |
*Polymorphism, Single Nucleotide | 9 | 1.0 |
Butadienes/pharmacology | 2 | 3.0 |
Dexamethasone/pharmacology | 4 | 0.0 |
Glucocorticoids/*pharmacology | 3 | 1.0 |
MAP Kinase Kinase 1 | 2 | 1.0 |
Mitogen-Activated Protein Kinase Kinases/*metabolism | 2 | 3.0 |
Nitriles/pharmacology | 3 | 2.0 |
Genes, Regulator | 14 | 13.0 |
PC12 Cells | 6 | 1.0 |
DNA-Binding Proteins/metabolism/*pharmacology | 4 | 66.0 |
Sertoli Cells/*metabolism | 2 | 20.0 |
Transcription Factor, Sp1/metabolism/*pharmacology | 5 | 100.0 |
Transcription, Genetic/drug effects | 34 | 5.0 |
RNA/metabolism | 9 | 1.0 |
Chloramphenicol O-Acetyltransferase/genetics/metabolism | 26 | 15.0 |
Cytochrome P-450 Enzyme System/*genetics | 8 | 1.0 |
Phosphoproteins/genetics/metabolism | 2 | 2.0 |
Steroid Hydroxylases/*genetics | 3 | 3.0 |
*Evolution, Molecular | 3 | 0.0 |
Phylogeny | 16 | 1.0 |
Species Specificity | 32 | 1.0 |
Zinc Fingers/genetics | 16 | 8.0 |
Transcription Factor, Sp1 | 36 | 100.0 |
Acetylation/drug effects | 5 | 18.0 |
*Gene Expression Regulation, Enzymologic/drug effects | 9 | 20.0 |
Hydroxamic Acids/*pharmacology | 8 | 17.0 |
Cell Line, Transformed | 27 | 1.0 |
Cytosine | 6 | 7.0 |
Guanine | 7 | 9.0 |
Lung | 4 | 4.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
*DNA Footprinting | 2 | 25.0 |
Hydroxysteroid Dehydrogenases/*genetics | 2 | 11.0 |
Immediate-Early Proteins/*genetics | 4 | 6.0 |
*Neoplasm Proteins | 6 | 0.0 |
Protein p53/*physiology | 6 | 4.0 |
Cyclins/*genetics | 19 | 13.0 |
*Papillomavirus, Human | 2 | 6.0 |
*Cloning, Molecular | 12 | 3.0 |
DNA-Binding Proteins/pharmacology | 2 | 8.0 |
Epithelial Cells | 6 | 1.0 |
Recombinant Proteins/pharmacology | 6 | 0.0 |
Sodium-Hydrogen Antiporter/*genetics | 3 | 60.0 |
Transcription Factor, Sp1/pharmacology | 2 | 100.0 |
*Gene Expression Regulation, Neoplastic/drug effects | 3 | 5.0 |
Luciferases/biosynthesis/genetics | 8 | 14.0 |
Neoplasm Invasiveness/*genetics | 3 | 8.0 |
Recombinant Fusion Proteins/biosynthesis | 56 | 13.0 |
Tumor Cells, Cultured/drug effects/metabolism | 4 | 2.0 |
Cell Compartmentation | 2 | 0.0 |
Nuclear Proteins/genetics/*metabolism | 11 | 3.0 |
Peptides/genetics | 2 | 2.0 |
Receptors, Nerve Growth Factor/*genetics | 2 | 6.0 |
ATP-Binding Cassette Transporters/*genetics | 2 | 0.0 |
DNA, Complementary | 41 | 2.0 |
*Regulatory Sequences, Nucleic Acid | 49 | 16.0 |
Sterols/*metabolism | 3 | 9.0 |
DNA-Binding Proteins/chemistry/metabolism | 3 | 8.0 |
Herpes Simplex Virus Protein Vmw65/metabolism | 4 | 30.0 |
Microscopy, Electron | 7 | 0.0 |
Recombinant Proteins/genetics/metabolism | 20 | 3.0 |
Calcium-Binding Proteins/*genetics | 4 | 4.0 |
Tandem Repeat Sequences | 2 | 1.0 |
*Alternative Splicing | 13 | 2.0 |
GC Rich Sequence/genetics | 4 | 18.0 |
Protein Isoforms/genetics | 9 | 3.0 |
RNA, Messenger | 12 | 2.0 |
Transcription Factor, Sp1/genetics | 30 | 81.0 |
*Transcription Initiation Site | 2 | 28.0 |
Casein Kinase II | 6 | 5.0 |
Protein-Serine-Threonine Kinases/*chemistry/*genetics | 2 | 33.0 |
Nucleic Acid Conformation | 18 | 3.0 |
Proteolipids/*genetics | 3 | 30.0 |
Pulmonary Surfactants/*genetics | 2 | 15.0 |
*Antigens, CD | 4 | 0.0 |
*Antigens, Neoplasm | 2 | 1.0 |
DNA-Binding Proteins/genetics/*metabolism | 51 | 5.0 |
Transcription Factors/genetics/*metabolism | 49 | 6.0 |
CCAAT-Enhancer-Binding Proteins/genetics | 2 | 22.0 |
Mutation/physiology | 4 | 3.0 |
Osmolar Concentration | 6 | 0.0 |
Cell Nucleus/chemistry | 8 | 4.0 |
Gene Fusion | 2 | 2.0 |
Nuclear Proteins/*metabolism | 31 | 4.0 |
Telomerase/*genetics/metabolism | 8 | 40.0 |
*Up-Regulation | 7 | 2.0 |
Bone Density/genetics | 4 | 18.0 |
Collagen Type I/genetics | 2 | 14.0 |
*Genetic Predisposition to Disease | 4 | 0.0 |
Osteoporosis, Postmenopausal/*genetics | 3 | 21.0 |
Polymorphism, Genetic | 19 | 0.0 |
Receptors, Calcitriol/genetics | 4 | 8.0 |
Cycloheximide/pharmacology | 9 | 1.0 |
Transcription, Genetic/*drug effects | 20 | 6.0 |
Cell Cycle Proteins/*genetics/metabolism | 4 | 7.0 |
Cyclin-Dependent Kinases/antagonists & inhibitors | 3 | 3.0 |
Proto-Oncogene Proteins c-myc/*genetics/metabolism | 2 | 16.0 |
Transforming Growth Factor beta/*genetics/metabolism | 2 | 11.0 |
Genes, myc | 3 | 1.0 |
Genes, ras | 6 | 2.0 |
Phosphoproteins/*metabolism | 4 | 0.0 |
DNA-Binding Proteins/drug effects/*metabolism | 2 | 11.0 |
Disease Models, Animal | 5 | 0.0 |
Lipoprotein Lipase/*genetics | 2 | 1.0 |
Transcription, Genetic/*physiology | 22 | 11.0 |
Hypercholesterolemia, Familial/*genetics | 2 | 4.0 |
*Point Mutation | 3 | 0.0 |
Receptors, LDL/*genetics | 7 | 4.0 |
Gene Expression Regulation/drug effects/physiology | 2 | 3.0 |
Intercellular Adhesion Molecule-1/*biosynthesis/genetics | 2 | 10.0 |
Transcription Factor AP-1/*physiology | 4 | 11.0 |
Glycosylation | 11 | 1.0 |
Interleukin-2/pharmacology | 2 | 0.0 |
Mitosis | 2 | 0.0 |
Phosphoprotein Phosphatase/*physiology | 2 | 15.0 |
T-Lymphocytes/*metabolism | 6 | 1.0 |
Transcription Factor, Sp1/*biosynthesis | 7 | 100.0 |
DNA-Binding Proteins/*pharmacology | 6 | 17.0 |
Promoter Regions (Genetics)/drug effects | 19 | 15.0 |
Transcription Factor, Sp1/*pharmacology | 5 | 100.0 |
Transcription Factors/*pharmacology | 7 | 28.0 |
Intercalating Agents/pharmacology | 2 | 16.0 |
Promoter Regions (Genetics)/drug effects/genetics | 3 | 9.0 |
Cathepsins/*genetics | 2 | 8.0 |
DNA, Neoplasm/genetics/metabolism | 6 | 7.0 |
CCAAT-Binding Factor/*physiology | 2 | 100.0 |
Receptors, Nicotinic/*genetics | 4 | 6.0 |
Consensus Sequence/genetics | 9 | 18.0 |
Dogs | 8 | 0.0 |
Stereoisomerism | 4 | 1.0 |
Transcription Factor AP-1/genetics | 4 | 14.0 |
Cytomegalovirus/*physiology | 2 | 7.0 |
Enhancer Elements (Genetics)/*physiology | 5 | 35.0 |
Virus Replication | 16 | 1.0 |
Gene Products, tat/*metabolism | 8 | 8.0 |
HIV-1/*metabolism | 4 | 1.0 |
Insects | 3 | 1.0 |
Alkylation | 2 | 2.0 |
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 0.0 |
Transcription Factors/*chemistry/genetics | 2 | 20.0 |
Zinc | 2 | 8.0 |
Membrane Proteins/biosynthesis/*genetics | 2 | 4.0 |
GC Rich Sequence/*physiology | 2 | 66.0 |
Genes, Homeobox | 2 | 2.0 |
Homeodomain Proteins/*genetics | 4 | 0.0 |
Leukemia, Myeloid, Chronic | 4 | 17.0 |
Trans-Activation (Genetics)/physiology | 6 | 6.0 |
Gene Therapy | 4 | 1.0 |
Antibiotics, Antineoplastic/pharmacology | 5 | 6.0 |
Cell Nucleus/drug effects/physiology | 2 | 28.0 |
*Genes, Immediate-Early | 2 | 6.0 |
Trans-Activation (Genetics)/*physiology | 10 | 8.0 |
*Saccharomyces cerevisiae Proteins | 28 | 2.0 |
TATA Box/genetics | 10 | 22.0 |
CpG Islands/genetics | 8 | 5.0 |
Genes, Reporter/genetics | 25 | 9.0 |
Crosses, Genetic | 6 | 0.0 |
*Gene Expression Regulation, Developmental | 11 | 1.0 |
Liver/enzymology | 4 | 0.0 |
Azacitidine/*analogs & derivatives/pharmacology | 6 | 8.0 |
Enzyme Induction | 11 | 1.0 |
HL-60 Cells | 10 | 1.0 |
3T3 Cells/metabolism | 2 | 7.0 |
Enhancer Elements (Genetics)/*genetics | 9 | 13.0 |
Gene Expression Regulation/*genetics | 15 | 10.0 |
Introns/*genetics | 3 | 1.0 |
Antigens, CD14/*genetics | 2 | 5.0 |
Hepatocytes/metabolism | 2 | 2.0 |
Monocytes/metabolism | 3 | 0.0 |
CCAAT-Binding Factor/physiology | 3 | 50.0 |
DNA-Binding Proteins/genetics/physiology | 4 | 5.0 |
Receptors, Transforming Growth Factor beta/*genetics | 2 | 4.0 |
Transcription Factor, Sp1/genetics/*physiology | 11 | 100.0 |
Transcription Factors/genetics/physiology | 5 | 8.0 |
Aged, 80 and over | 18 | 0.0 |
*Bone Density | 3 | 2.0 |
Collagen Type I/*genetics | 4 | 19.0 |
*Polymorphism, Genetic | 22 | 0.0 |
CCAAT-Enhancer-Binding Proteins/*metabolism | 5 | 17.0 |
Culture Techniques | 3 | 0.0 |
Rabbits | 27 | 0.0 |
Dimerization | 13 | 0.0 |
Osteocalcin/*genetics | 2 | 9.0 |
Proto-Oncogene Proteins c-jun/biosynthesis | 2 | 10.0 |
Mitochondrial ADP, ATP Translocases/*genetics/metabolism | 2 | 100.0 |
Repressor Proteins/genetics/metabolism | 3 | 3.0 |
DNA, Viral | 12 | 7.0 |
*HIV Long Terminal Repeat | 12 | 13.0 |
*HIV Long-Term Survivors | 2 | 10.0 |
Protein Binding/drug effects | 13 | 3.0 |
Regulatory Sequences, Nucleic Acid/genetics | 12 | 15.0 |
Neoplasm Proteins/*genetics/metabolism | 2 | 1.0 |
Protein Kinase C/metabolism | 11 | 2.0 |
Transcription Factor AP-1/genetics/*metabolism | 5 | 19.0 |
Tumor Markers, Biological | 4 | 0.0 |
Gene Expression Regulation, Neoplastic/drug effects/physiology | 3 | 7.0 |
Indoles/pharmacology | 5 | 2.0 |
Antioxidants/metabolism | 2 | 2.0 |
Chromatography, High Pressure Liquid | 8 | 0.0 |
Genetic Predisposition to Disease | 6 | 0.0 |
Superoxide Dismutase/*genetics | 7 | 3.0 |
Antibiotics, Antineoplastic/*pharmacology | 2 | 1.0 |
Apoptosis/drug effects | 6 | 0.0 |
Cell Division/drug effects | 16 | 0.0 |
Doxorubicin/*pharmacology | 2 | 2.0 |
Drug Resistance, Neoplasm | 3 | 0.0 |
Oligonucleotides/genetics | 3 | 8.0 |
Chromatin Assembly and Disassembly | 2 | 50.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/*genetics | 3 | 16.0 |
Transcription Factor AP-1/*metabolism | 10 | 6.0 |
Kidney/*metabolism | 3 | 1.0 |
Trans-Activators/*physiology | 12 | 4.0 |
Transforming Growth Factor beta/*physiology | 2 | 1.0 |
*Protein Processing, Post-Translational | 2 | 0.0 |
Locus Control Region | 2 | 40.0 |
Papillomavirus, Human/*genetics | 10 | 13.0 |
Variation (Genetics) | 16 | 0.0 |
*Gene Therapy | 2 | 0.0 |
Progestins/metabolism | 2 | 50.0 |
Thromboplastin/*biosynthesis | 2 | 2.0 |
Endothelium, Vascular/metabolism | 6 | 2.0 |
Receptors, Retinoic Acid/*metabolism | 2 | 3.0 |
Retinoid X Receptors | 9 | 3.0 |
Transforming Growth Factor beta/genetics | 3 | 3.0 |
Cell Extracts | 13 | 9.0 |
Trans-Activators/genetics/*physiology | 2 | 2.0 |
Biological Markers/blood | 9 | 0.0 |
Chorionic Gonadotropin/analysis | 13 | 40.0 |
Chromosome Disorders | 4 | 1.0 |
Pregnancy/*blood | 8 | 5.0 |
Pregnancy Trimester, First | 35 | 12.0 |
Pregnancy-Associated Plasma Protein-A/*analysis | 11 | 61.0 |
Prenatal Diagnosis | 6 | 3.0 |
Reference Values | 22 | 0.0 |
alpha-Fetoproteins/analysis | 13 | 4.0 |
Cystathionine beta-Synthase/*genetics | 3 | 6.0 |
*Chemokines, CXC | 3 | 4.0 |
Colon/*metabolism | 2 | 3.0 |
Epithelial Cells/metabolism | 8 | 2.0 |
NF-kappa B/*physiology | 4 | 4.0 |
Zinc/metabolism | 2 | 2.0 |
Epithelial Cells/*enzymology | 2 | 20.0 |
ras Proteins/metabolism | 2 | 1.0 |
Down-Regulation/physiology | 3 | 3.0 |
Endothelial Growth Factors/*biosynthesis/genetics | 3 | 2.0 |
Gene Expression Regulation, Neoplastic/*physiology | 6 | 3.0 |
Lymphokines/*biosynthesis/genetics | 3 | 2.0 |
Protein p53/metabolism/*physiology | 2 | 16.0 |
src-Family Kinases/metabolism | 2 | 1.0 |
Diabetes Mellitus, Type 2/*genetics | 2 | 1.0 |
Gene Frequency | 11 | 0.0 |
Genotype | 20 | 0.0 |
Polymorphism, Single Nucleotide/*genetics | 3 | 1.0 |
Amino Acid Substitution | 3 | 0.0 |
Oligodeoxyribonucleotides/metabolism | 8 | 18.0 |
Protein Binding/genetics | 12 | 5.0 |
Thermodynamics | 2 | 0.0 |
Transcription Factor, Sp1/chemistry/*genetics/metabolism | 2 | 100.0 |
Bone Density | 3 | 2.0 |
Cohort Studies | 3 | 0.0 |
Genetic Screening | 5 | 0.0 |
Predictive Value of Tests | 6 | 0.0 |
Prevalence | 2 | 0.0 |
Phosphoproteins/*physiology | 2 | 2.0 |
Receptor, Epidermal Growth Factor/*genetics | 8 | 3.0 |
Repressor Proteins/*physiology | 3 | 2.0 |
Gene Expression Regulation, Viral | 26 | 9.0 |
Herpesvirus 4, Human/*genetics | 13 | 17.0 |
Virus Latency/genetics | 3 | 27.0 |
Conserved Sequence/genetics | 3 | 1.0 |
K562 Cells | 18 | 4.0 |
Proto-Oncogene Proteins/genetics/metabolism | 4 | 2.0 |
Breast Neoplasms/*genetics | 4 | 0.0 |
Butyrates/*pharmacology | 10 | 23.0 |
Histone Deacetylases/*antagonists & inhibitors | 6 | 12.0 |
Insulin-Like Growth Factor Binding Protein 3/*genetics | 2 | 15.0 |
Response Elements/physiology | 3 | 9.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
G(M2) Activator Protein | 2 | 11.0 |
Introns/genetics | 24 | 3.0 |
Hepatitis B virus/*genetics | 4 | 13.0 |
Trans-Activators/genetics | 7 | 3.0 |
Antimetabolites, Antineoplastic/*pharmacology | 2 | 2.0 |
DNA Modification Methylases/antagonists & inhibitors | 2 | 7.0 |
DNA, Complementary/genetics/metabolism | 4 | 8.0 |
Genetic Vectors/genetics | 3 | 1.0 |
Tumor Cells, Cultured/drug effects | 5 | 0.0 |
Lipopolysaccharides/*pharmacology | 2 | 0.0 |
Receptors, Cytoplasmic and Nuclear/metabolism | 2 | 1.0 |
DNA-Binding Proteins/metabolism/*physiology | 9 | 7.0 |
Transcription Factors/metabolism/*physiology | 14 | 14.0 |
Chickens | 7 | 0.0 |
DNA-Binding Proteins/*chemistry/*metabolism | 2 | 3.0 |
Glucose/metabolism | 2 | 0.0 |
Pyruvate Kinase/*genetics | 2 | 18.0 |
Rats, Sprague-Dawley | 27 | 1.0 |
Transcription Factors/*chemistry/*metabolism | 3 | 7.0 |
Introns | 107 | 5.0 |
Phosphoproteins/*genetics/*metabolism | 2 | 14.0 |
Chloramphenicol O-Acetyltransferase/biosynthesis/genetics | 4 | 12.0 |
Lac Operon | 2 | 1.0 |
Nerve Tissue Proteins/*genetics | 9 | 1.0 |
Neurons/metabolism | 2 | 0.0 |
Nuclear Proteins/*genetics | 12 | 2.0 |
*Trinucleotide Repeats | 2 | 1.0 |
beta-Galactosidase/biosynthesis | 4 | 8.0 |
Acid Phosphatase/*genetics/metabolism | 2 | 33.0 |
Alkaline Phosphatase/metabolism | 3 | 2.0 |
Cathepsin B/*genetics/metabolism | 2 | 66.0 |
beta-Galactosidase/metabolism | 3 | 1.0 |
WT1 Proteins | 6 | 2.0 |
Histone Deacetylases/*metabolism | 5 | 4.0 |
DNA/analysis | 17 | 1.0 |
Interferon Type II/pharmacology | 6 | 1.0 |
Tetradecanoylphorbol Acetate/*pharmacology | 13 | 4.0 |
Tyrosine/metabolism | 5 | 0.0 |
DNA Probes | 22 | 2.0 |
Neoplasm Proteins/biosynthesis | 2 | 2.0 |
Proteins/*metabolism | 4 | 0.0 |
T-Lymphocytes | 7 | 2.0 |
B-Lymphocytes/metabolism | 6 | 3.0 |
Interleukin-10/*genetics | 2 | 4.0 |
Exons/*genetics | 3 | 0.0 |
Prions/*genetics | 2 | 3.0 |
Transcription Factor, Sp1/analysis | 2 | 100.0 |
DNA/genetics | 39 | 2.0 |
Chloramphenicol O-Acetyltransferase/genetics | 32 | 11.0 |
Heterogeneous-Nuclear Ribonucleoproteins | 3 | 2.0 |
Protein-Serine-Threonine Kinases/*genetics/metabolism | 2 | 3.0 |
Radiation, Ionizing | 3 | 2.0 |
Adrenal Gland Neoplasms | 3 | 18.0 |
Steroid 17-alpha-Hydroxylase/*genetics | 2 | 6.0 |
Structure-Activity Relationship | 33 | 1.0 |
Breast Neoplasms/*genetics/metabolism | 5 | 4.0 |
Estradiol/pharmacology | 8 | 3.0 |
Protein Precursors/*genetics/metabolism | 3 | 17.0 |
Receptors, Estrogen/*metabolism | 4 | 1.0 |
Glycerolphosphate Dehydrogenase/*genetics | 2 | 33.0 |
Mitochondria/*enzymology | 8 | 6.0 |
Receptors, Thyroid Hormone/metabolism | 2 | 5.0 |
Enzyme Activation/drug effects | 7 | 0.0 |
Enzyme Inhibitors/*pharmacology | 9 | 1.0 |
Gene Expression Regulation, Enzymologic/drug effects | 5 | 3.0 |
Telomerase/genetics/*metabolism | 2 | 8.0 |
Cell Differentiation/physiology | 4 | 0.0 |
Antigens, CD/*genetics | 16 | 6.0 |
*Activin Receptors, Type I | 2 | 8.0 |
Azacitidine/*pharmacology | 2 | 12.0 |
Colonic Neoplasms | 3 | 2.0 |
DNA-Binding Proteins/*genetics/*metabolism | 13 | 9.0 |
Gene Expression Regulation/drug effects/*physiology | 2 | 2.0 |
Gene Expression Regulation, Neoplastic/*drug effects | 11 | 4.0 |
Protein-Serine-Threonine Kinases/*genetics | 8 | 2.0 |
CCAAT-Enhancer-Binding Proteins/metabolism | 4 | 9.0 |
*Carrier Proteins | 21 | 3.0 |
Culture Media, Serum-Free | 2 | 0.0 |
DNA Polymerase II/*genetics | 2 | 33.0 |
Mutation/genetics | 18 | 1.0 |
Nuclease Protection Assays | 2 | 10.0 |
RNA, Messenger/analysis/genetics | 7 | 1.0 |
Response Elements/*genetics | 7 | 12.0 |
Trans-Activators/physiology | 6 | 4.0 |
Transcription Factor, Sp1/chemistry/*physiology | 2 | 100.0 |
Vascular Cell Adhesion Molecule-1/*genetics | 2 | 22.0 |
Blotting, Southern | 35 | 1.0 |
*Gene Expression Profiling | 3 | 0.0 |
*Introns | 14 | 6.0 |
Case-Control Studies | 6 | 0.0 |
Cell Count | 2 | 0.0 |
Keratoconus/*metabolism/pathology | 2 | 66.0 |
Oligonucleotide Probes | 32 | 5.0 |
Promoter Regions (Genetics)/genetics/physiology | 4 | 21.0 |
*Repressor Proteins | 19 | 1.0 |
*Chromosome Mapping | 14 | 0.0 |
Repressor Proteins/*genetics | 6 | 2.0 |
Chromones/pharmacology | 2 | 0.0 |
Liver Neoplasms/metabolism | 3 | 4.0 |
Morpholines/pharmacology | 2 | 0.0 |
Plasminogen Activator Inhibitor 1/biosynthesis/*genetics | 3 | 50.0 |
Receptors, Estrogen/genetics | 2 | 3.0 |
Gene Expression Regulation/genetics | 13 | 6.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/*genetics/metabolism | 2 | 28.0 |
Mice, Inbred C57BL | 19 | 0.0 |
Mice, Inbred CBA | 6 | 1.0 |
Transcription Factor, Sp1/genetics/metabolism/*physiology | 7 | 100.0 |
Mucins/*genetics | 4 | 3.0 |
Protein Kinase C/physiology | 4 | 2.0 |
Transcription Factors/physiology | 23 | 10.0 |
Transforming Growth Factor alpha/physiology | 2 | 7.0 |
Oligodeoxyribonucleotides/chemistry | 16 | 7.0 |
Recombinant Proteins/biosynthesis | 24 | 5.0 |
Placenta/metabolism | 12 | 6.0 |
*Genome, Viral | 4 | 5.0 |
Viral Matrix Proteins/*genetics | 4 | 25.0 |
Gonadorelin/*pharmacology | 2 | 5.0 |
Signal Transduction/*drug effects | 4 | 1.0 |
Gelatinase A/*genetics | 3 | 33.0 |
Multienzyme Complexes/biosynthesis/*genetics | 2 | 33.0 |
Models, Molecular | 12 | 0.0 |
Transcription Factors/*chemistry | 2 | 4.0 |
Liver/*metabolism | 6 | 1.0 |
Trans-Activators/genetics/*metabolism | 9 | 2.0 |
Tumor Necrosis Factor-alpha/*metabolism | 3 | 0.0 |
Escherichia coli | 4 | 0.0 |
Genes, p53 | 5 | 1.0 |
Keratinocytes | 2 | 5.0 |
Protein p53/genetics/*metabolism | 3 | 1.0 |
DNA Damage | 8 | 0.0 |
Antibodies | 2 | 0.0 |
Genes, Viral/*genetics | 2 | 10.0 |
Cell Adhesion Molecules/*genetics | 7 | 7.0 |
Flow Cytometry | 12 | 0.0 |
*I-kappa B | 4 | 2.0 |
Adenocarcinoma/metabolism | 2 | 2.0 |
Glycoproteins/*genetics | 8 | 4.0 |
Pregnancy Proteins/*genetics | 10 | 29.0 |
Mammals/genetics | 2 | 3.0 |
Proto-Oncogene Proteins/genetics/*metabolism | 2 | 0.0 |
Chromosomes, Human, Pair 14 | 3 | 1.0 |
Databases, Factual | 2 | 0.0 |
Adenocarcinoma/genetics/*metabolism | 3 | 17.0 |
Deoxyribonucleases/metabolism | 3 | 17.0 |
Liver/metabolism | 11 | 1.0 |
Pseudogenes | 6 | 3.0 |
Oncogene Proteins, Viral/genetics/*metabolism | 2 | 6.0 |
Proto-Oncogene Proteins c-myc/genetics/metabolism | 2 | 6.0 |
*RNA | 6 | 18.0 |
Collagen/genetics | 5 | 5.0 |
Gene Expression/drug effects/*physiology | 2 | 20.0 |
Combined Modality Therapy | 2 | 0.0 |
Spain | 2 | 0.0 |
Estradiol/*physiology | 3 | 20.0 |
Receptors, Estrogen/*physiology | 3 | 9.0 |
Mutagenesis, Insertional | 9 | 3.0 |
Trans-Activation (Genetics)/immunology | 2 | 8.0 |
Transcription, Genetic/*immunology | 2 | 6.0 |
DNA Primers/genetics | 32 | 2.0 |
Galactosyltransferases/*genetics | 2 | 20.0 |
RNA/genetics/isolation & purification | 4 | 3.0 |
Catalytic Domain | 3 | 1.0 |
Mesocricetus | 3 | 1.0 |
Pregnancy Proteins/metabolism | 4 | 25.0 |
Enzyme Activation/genetics | 3 | 3.0 |
Heterotrimeric GTP-Binding Proteins/*genetics | 2 | 4.0 |
Mitogen-Activated Protein Kinases/*genetics | 2 | 25.0 |
Signal Transduction/drug effects/genetics | 2 | 5.0 |
Isoenzymes/*genetics | 5 | 1.0 |
Integrins/*genetics | 4 | 22.0 |
Prostatic Neoplasms/*metabolism | 2 | 1.0 |
Insulin-Like Growth Factor II/*genetics/metabolism | 4 | 26.0 |
Mammary Glands, Animal/*metabolism | 2 | 10.0 |
Trans-Activators/*genetics | 14 | 4.0 |
Virus Activation/*genetics | 2 | 28.0 |
Gene Expression Regulation, Neoplastic/drug effects | 12 | 2.0 |
Insulin-Like Growth Factor II/*genetics | 3 | 2.0 |
Mitogen-Activated Protein Kinase 1/*metabolism | 3 | 2.0 |
Mitogen-Activated Protein Kinase 3 | 9 | 1.0 |
Protein Kinase C/antagonists & inhibitors/*metabolism | 4 | 4.0 |
RNA, Neoplasm/genetics/metabolism | 3 | 2.0 |
Protein Kinases/*metabolism | 5 | 1.0 |
*Health Policy | 3 | 8.0 |
International Cooperation | 2 | 2.0 |
Biotransformation | 2 | 0.0 |
Cyclophosphamide/pharmacokinetics/toxicity | 2 | 18.0 |
Cytochrome P-450 Enzyme System/administration & dosage/*metabolism | 2 | 20.0 |
Phase Transition | 2 | 12.0 |
Toxicity Tests/*methods | 2 | 15.0 |
Chromatin Immunoprecipitation | 2 | 5.0 |
HIV-1/genetics/*metabolism | 4 | 5.0 |
*Mutation | 14 | 0.0 |
Virus Assembly | 4 | 14.0 |
Viral Proteins/genetics/*metabolism | 2 | 3.0 |
Astrocytes/*virology | 3 | 42.0 |
Gene Products, vpr/*physiology | 2 | 50.0 |
HIV Long Terminal Repeat | 13 | 9.0 |
Protein p53/physiology | 4 | 5.0 |
DNA, Complementary/*genetics | 4 | 1.0 |
Serine Endopeptidases/*genetics | 3 | 5.0 |
Protein Folding | 2 | 0.0 |
Protein-Tyrosine-Phosphatase/*genetics | 3 | 2.0 |
Antigens, CD/biosynthesis/*genetics | 3 | 11.0 |
Blood Platelets/metabolism | 2 | 1.0 |
Genes | 3 | 1.0 |
Integrin alpha2 | 4 | 20.0 |
Integrins/metabolism | 2 | 1.0 |
Receptors, Collagen | 2 | 2.0 |
Thymidine Kinase/genetics | 12 | 14.0 |
Repressor Proteins/metabolism | 14 | 7.0 |
Globins/*genetics/metabolism | 2 | 22.0 |
*Locus Control Region | 3 | 37.0 |
Adenosine Triphosphate/metabolism | 6 | 1.0 |
Calcium/metabolism | 4 | 0.0 |
Gene Expression/physiology | 2 | 0.0 |
Luciferases | 5 | 12.0 |
Reactive Oxygen Species/metabolism | 2 | 0.0 |
Stress, Mechanical | 4 | 1.0 |
Umbilical Veins/cytology | 2 | 0.0 |
Cell Cycle/*drug effects | 2 | 1.0 |
*Cyclin-Dependent Kinases | 4 | 2.0 |
Gene Expression Regulation, Enzymologic/*drug effects | 9 | 6.0 |
Indoles/*pharmacology | 2 | 2.0 |
Acetyltransferases/*metabolism | 3 | 3.0 |
Cell Cycle Proteins/*metabolism | 7 | 2.0 |
*CDC2-CDC28 Kinases | 4 | 0.0 |
Cyclin A/metabolism | 2 | 2.0 |
Cyclin-Dependent Kinases/metabolism | 2 | 0.0 |
Fibroblasts | 10 | 1.0 |
Purines/pharmacology | 4 | 7.0 |
S Phase | 4 | 1.0 |
Receptors, Cytoplasmic and Nuclear/physiology | 2 | 6.0 |
Syndrome | 5 | 0.0 |
Gene Expression Regulation, Developmental | 20 | 1.0 |
*Cell Differentiation | 3 | 1.0 |
Telomerase/*antagonists & inhibitors/genetics/metabolism | 2 | 66.0 |
Colonic Neoplasms/*genetics/pathology | 2 | 4.0 |
DNA Damage/drug effects | 2 | 4.0 |
*Genes, p53 | 6 | 1.0 |
*Gene Expression Regulation/drug effects | 15 | 7.0 |
Mammals | 6 | 1.0 |
Metallothionein/*genetics | 3 | 20.0 |
Zinc/*pharmacology | 2 | 6.0 |
Proto-Oncogene Proteins/*genetics/metabolism | 6 | 4.0 |
Imidazoles/pharmacology | 3 | 1.0 |
Pyridines/pharmacology | 2 | 0.0 |
Chloramphenicol O-Acetyltransferase/metabolism | 14 | 12.0 |
Epidermal Growth Factor/*metabolism | 3 | 0.0 |
Retroviridae/genetics | 3 | 0.0 |
Codon | 8 | 1.0 |
Receptors, Somatostatin/*genetics | 2 | 7.0 |
*Trans-Activation (Genetics)/drug effects | 6 | 14.0 |
*DNA Helicases | 5 | 2.0 |
DNA Repair/genetics | 2 | 1.0 |
Trans-Activators/*genetics/*metabolism | 5 | 14.0 |
*Transcription Factors, TFII | 2 | 1.0 |
Adenocarcinoma/*genetics/pathology | 2 | 2.0 |
Mucins/*genetics/metabolism | 2 | 7.0 |
Electrophoresis/methods | 7 | 7.0 |
Fibroblasts/cytology/metabolism | 6 | 3.0 |
*Proto-Oncogene Proteins | 15 | 0.0 |
Skin/cytology/*metabolism | 2 | 5.0 |
Neurons/*physiology | 3 | 2.0 |
Islets of Langerhans/*metabolism | 2 | 3.0 |
Podophyllin/*analogs & derivatives/*metabolism | 2 | 100.0 |
Biological Transport | 4 | 0.0 |
Cell Membrane/metabolism | 4 | 0.0 |
Cholesterol/metabolism | 3 | 1.0 |
Mice, Knockout | 6 | 0.0 |
Molecular Structure | 3 | 0.0 |
Phospholipids/metabolism | 2 | 1.0 |
Epithelium/metabolism | 2 | 0.0 |
DNA-Binding Proteins/*metabolism/pharmacology | 2 | 15.0 |
Regulatory Sequences, Nucleic Acid/drug effects | 2 | 18.0 |
Transcription Factor, Sp1/*metabolism/pharmacology | 3 | 75.0 |
Transcription Factors/*metabolism/pharmacology | 2 | 18.0 |
Transcription Factors/*genetics/*physiology | 3 | 10.0 |
Apoptosis/*physiology | 2 | 0.0 |
Lipoproteins, LDL/*pharmacology | 3 | 5.0 |
Monocytes/drug effects/*metabolism | 2 | 1.0 |
Hydroxyl Radical | 2 | 6.0 |
Transcription Factor, Sp1/chemistry/metabolism | 5 | 100.0 |
Cyclosporine/pharmacology | 3 | 1.0 |
Lymphocyte Activation/genetics | 2 | 2.0 |
Membrane Glycoproteins/*biosynthesis/genetics | 2 | 3.0 |
5' Untranslated Regions/*genetics | 4 | 8.0 |
Chondrocytes/metabolism | 3 | 7.0 |
Cell Adhesion | 3 | 0.0 |
Culture Media, Conditioned | 4 | 1.0 |
Plasminogen Inactivators/*metabolism | 2 | 11.0 |
Skin/metabolism | 8 | 4.0 |
Tyrosine/*metabolism | 2 | 0.0 |
Electrophoresis | 12 | 4.0 |
Estrogen Receptor alpha | 12 | 5.0 |
DNA/chemistry/genetics/isolation & purification | 5 | 9.0 |
Antibodies, Monoclonal/*immunology | 2 | 0.0 |
Antigens, CD98 | 2 | 18.0 |
Cell Aggregation | 2 | 1.0 |
Protein-Tyrosine Kinase/genetics | 2 | 1.0 |
Receptors, Cytoplasmic and Nuclear/genetics/physiology | 2 | 33.0 |
Tumor Necrosis Factor-alpha/physiology | 2 | 1.0 |
Colonic Neoplasms/metabolism | 3 | 5.0 |
Dose-Response Relationship, Radiation | 4 | 1.0 |
Liposomes/metabolism | 2 | 3.0 |
Membrane Proteins/genetics/*metabolism | 2 | 0.0 |
Protein Kinases/metabolism | 4 | 0.0 |
Receptors, Calcitriol/*genetics | 2 | 0.0 |
Apolipoproteins/*genetics | 2 | 2.0 |
Receptors, Cell Surface/genetics/*metabolism | 2 | 1.0 |
Signal Transduction/*physiology | 7 | 0.0 |
Chromosomes, Human, Pair 1/genetics | 3 | 1.0 |
DNA, Complementary/chemistry/genetics | 8 | 2.0 |
Genes, Structural/*genetics | 14 | 5.0 |
Cyclins/genetics | 5 | 3.0 |
Gene Expression Regulation, Viral/*drug effects | 4 | 14.0 |
Human T-lymphotropic virus 1/*genetics | 7 | 13.0 |
Maleimides/pharmacology | 3 | 3.0 |
Terminal Repeat Sequences/*genetics | 2 | 20.0 |
Trans-Activation (Genetics)/drug effects | 13 | 6.0 |
Mice, Inbred Strains | 6 | 0.0 |
Recombinant Fusion Proteins/drug effects/genetics/metabolism | 3 | 15.0 |
Cell Nucleus/enzymology | 2 | 2.0 |
Cross-Linking Reagents/metabolism | 3 | 5.0 |
Guinea Pigs | 4 | 0.0 |
Transcription Factor, Sp1/drug effects/*metabolism | 2 | 100.0 |
Lung/metabolism | 3 | 1.0 |
beta-Galactosidase/genetics | 2 | 1.0 |
Cyclic AMP/*physiology | 3 | 3.0 |
Protein Processing, Post-Translational | 11 | 1.0 |
Transcription Factors/genetics/metabolism/*physiology | 4 | 7.0 |
DNA/chemistry | 11 | 4.0 |
Signal Transduction/drug effects/physiology | 3 | 1.0 |
*Membrane Transport Proteins | 13 | 2.0 |
Cyclic AMP/pharmacology | 10 | 9.0 |
Cyclic GMP/pharmacology | 2 | 11.0 |
Piperazines/pharmacology | 2 | 1.0 |
*Promoter Regions (Genetics)/drug effects | 9 | 23.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism | 2 | 0.0 |
GTP-Binding Proteins/*genetics | 3 | 2.0 |
Binding Sites/genetics/immunology | 3 | 6.0 |
DNA-Binding Proteins/genetics/metabolism/*physiology | 4 | 6.0 |
Gene Expression Regulation/immunology | 2 | 1.0 |
*Milk Proteins | 2 | 0.0 |
Protein Structure, Tertiary/genetics | 3 | 1.0 |
Polymorphism, Genetic/*genetics | 6 | 0.0 |
Up-Regulation/genetics | 3 | 3.0 |
Enzyme Activation/physiology | 3 | 1.0 |
Gastrins/*genetics | 7 | 63.0 |
Promoter Regions (Genetics)/*drug effects | 5 | 10.0 |
Drug Synergism | 9 | 0.0 |
Epidermal Growth Factor/pharmacology | 4 | 0.0 |
Protirelin/pharmacology | 2 | 1.0 |
Proto-Oncogene Proteins c-fos/*genetics | 2 | 8.0 |
Adrenal Cortex/*enzymology | 2 | 33.0 |
Receptors, Retinoic Acid | 5 | 9.0 |
*RNA-Binding Proteins | 5 | 1.0 |
Receptors, Lipoprotein/*genetics | 2 | 33.0 |
*Gene Expression Regulation/physiology | 2 | 40.0 |
Xenopus laevis/*genetics | 2 | 7.0 |
DNA/chemistry/genetics | 13 | 1.0 |
Isoenzymes/genetics | 5 | 1.0 |
Phosphofructokinase-1/*genetics | 3 | 18.0 |
Polyamines/metabolism | 2 | 15.0 |
S-Adenosylmethionine/metabolism | 2 | 10.0 |
DNA, Neoplasm/metabolism | 7 | 4.0 |
Chimera | 4 | 2.0 |
*Intercellular Signaling Peptides and Proteins | 3 | 0.0 |
Interleukin-1/pharmacology | 3 | 0.0 |
Wound Healing/physiology | 3 | 5.0 |
3' Untranslated Regions | 3 | 2.0 |
*Variation (Genetics) | 5 | 0.0 |
Proto-Oncogene Proteins/*physiology | 4 | 1.0 |
Transforming Growth Factor beta/*metabolism | 10 | 4.0 |
Adenovirus E1A Proteins/metabolism | 6 | 18.0 |
MAP Kinase Signaling System | 3 | 1.0 |
*Neuropeptides | 2 | 1.0 |
Cholesterol/*metabolism | 3 | 1.0 |
Intracellular Membranes/*metabolism | 2 | 3.0 |
Models, Chemical | 3 | 0.0 |
Sequence Homology | 4 | 1.0 |
Fluorescein-5-isothiocyanate | 2 | 1.0 |
Glioblastoma/genetics/metabolism | 2 | 33.0 |
Neoplasm Invasiveness | 3 | 0.0 |
Thromboplastin/*biosynthesis/genetics | 3 | 6.0 |
Transforming Growth Factor beta/*biosynthesis/genetics | 3 | 21.0 |
Genetic Markers | 4 | 0.0 |
*Genetic Vectors | 2 | 0.0 |
HIV Long Terminal Repeat/*genetics | 24 | 32.0 |
Liver/*physiology | 2 | 4.0 |
Nuclear Proteins/genetics/metabolism | 8 | 4.0 |
Cell Cycle Proteins/genetics | 2 | 2.0 |
Chromosomes, Human, Pair 15 | 2 | 1.0 |
Expressed Sequence Tags | 5 | 1.0 |
*Multigene Family | 8 | 1.0 |
Repressor Proteins/genetics | 4 | 2.0 |
Viral Proteins/*genetics | 8 | 10.0 |
Transcription Factors/metabolism/physiology | 3 | 14.0 |
Antibodies, Monoclonal/pharmacology | 2 | 0.0 |
Signal Transduction/drug effects | 11 | 1.0 |
Colonic Neoplasms/*genetics | 2 | 2.0 |
Drosophila/cytology | 9 | 75.0 |
Burkitt Lymphoma | 2 | 2.0 |
Cyclins/metabolism | 3 | 0.0 |
Chromatin/*metabolism | 5 | 4.0 |
Electrophoresis, Polyacrylamide Gel/methods | 3 | 2.0 |
Genes, Overlapping | 3 | 13.0 |
Gene Expression/drug effects | 12 | 1.0 |
Scleroderma, Systemic/*metabolism/*pathology | 2 | 40.0 |
Binding, Competitive/drug effects | 2 | 3.0 |
Fibroblasts/cytology | 2 | 0.0 |
Skin/cytology | 2 | 1.0 |
Tissue Inhibitor of Metalloproteinase-1/*genetics | 2 | 12.0 |
DNA, Neoplasm/genetics | 5 | 0.0 |
Cell Cycle/genetics | 3 | 2.0 |
Molecular Weight | 29 | 1.0 |
*Chromosomes, Human, Pair 16 | 2 | 0.0 |
Cosmids/genetics | 3 | 5.0 |
Brain/*metabolism | 5 | 1.0 |
Aorta | 7 | 4.0 |
Estradiol/analogs & derivatives/*pharmacology | 2 | 12.0 |
Estrogen Receptor beta | 2 | 2.0 |
Gene Expression Regulation/*drug effects/physiology | 2 | 11.0 |
Muscle, Smooth, Vascular/*metabolism | 3 | 6.0 |
Receptor, IGF Type 1/*genetics | 3 | 12.0 |
Receptors, Estrogen/genetics/*physiology | 2 | 28.0 |
Fibroblasts/enzymology | 5 | 2.0 |
RNA, Messenger/chemistry | 2 | 5.0 |
Reactive Oxygen Species | 2 | 1.0 |
Enzyme Induction/drug effects | 3 | 0.0 |
Promoter Regions (Genetics)/drug effects/*physiology | 2 | 15.0 |
Transcription Factors/genetics/metabolism/physiology | 2 | 33.0 |
Tretinoin/*metabolism/pharmacology | 2 | 11.0 |
Zebrafish | 2 | 1.0 |
Proteins/genetics/*metabolism | 2 | 0.0 |
RNA-Binding Proteins/genetics/metabolism | 2 | 7.0 |
*Two-Hybrid System Techniques | 2 | 11.0 |
Swine/*genetics | 2 | 1.0 |
RNA, Messenger/*genetics | 5 | 1.0 |
Fungal Proteins/metabolism | 11 | 7.0 |
Nuclear Proteins/genetics | 4 | 1.0 |
Repetitive Sequences, Nucleic Acid | 36 | 4.0 |
Carrier Proteins/*biosynthesis/genetics | 2 | 3.0 |
Adenosinetriphosphatase/metabolism | 2 | 1.0 |
Cell Nucleus/*metabolism | 7 | 1.0 |
Alu Elements/genetics | 2 | 7.0 |
Heterozygote | 7 | 0.0 |
Homozygote | 2 | 0.0 |
Phenotype | 22 | 0.0 |
DNA, Single-Stranded/chemistry/genetics/*metabolism | 2 | 50.0 |
CCAAT-Enhancer-Binding Proteins | 34 | 20.0 |
Trans-Activators/*genetics/metabolism | 5 | 4.0 |
Gene Expression Regulation, Neoplastic/physiology | 3 | 2.0 |
Lung/*metabolism | 2 | 2.0 |
Galactosyltransferases/*genetics/*metabolism | 2 | 100.0 |
Genetic Complementation Test | 7 | 1.0 |
Anthropometry | 3 | 1.0 |
*Base Sequence | 2 | 5.0 |
*Models, Genetic | 2 | 1.0 |
Lipids/metabolism | 2 | 0.0 |
Physical Chromosome Mapping | 3 | 0.0 |
*Proprotein Convertases | 2 | 13.0 |
Antibody Specificity | 5 | 0.0 |
Autoantibodies/*immunology | 2 | 0.0 |
Open Reading Frames | 10 | 1.0 |
Glutathione Transferase/*genetics | 4 | 0.0 |
Simian virus 40/genetics | 13 | 11.0 |
Drug Interactions | 2 | 0.0 |
Phosphoproteins/*genetics | 6 | 2.0 |
Antibodies, Monoclonal/metabolism | 3 | 0.0 |
Myocardium/metabolism | 4 | 1.0 |
Cyclin D1/*genetics | 3 | 4.0 |
Embryo | 5 | 1.0 |
Kidney | 11 | 2.0 |
Repressor Proteins/genetics/*physiology | 2 | 5.0 |
*CCAAT-Enhancer-Binding Proteins | 32 | 24.0 |
Interleukin-6/*pharmacology | 2 | 0.0 |
Iodine Radioisotopes/diagnostic use | 2 | 0.0 |
Liver/cytology | 5 | 7.0 |
Receptors, LDL/*genetics/metabolism | 2 | 7.0 |
Transcription, Genetic/drug effects/physiology | 2 | 5.0 |
Estrogens/metabolism | 5 | 6.0 |
Receptors, Estrogen/metabolism | 9 | 3.0 |
Receptors, Progesterone/*genetics/metabolism | 3 | 50.0 |
Response Elements/*physiology | 2 | 15.0 |
Transcription Factor, Sp1/isolation & purification/*metabolism | 6 | 100.0 |
Gene Expression Regulation, Viral/*physiology | 3 | 18.0 |
HIV-1/*genetics | 34 | 10.0 |
Cholecystokinin/*genetics | 2 | 10.0 |
Caspases/metabolism | 6 | 0.0 |
Cell Cycle/physiology | 3 | 0.0 |
Phospholipases A/*genetics | 2 | 9.0 |
*Phylogeny | 2 | 1.0 |
Transcription Factors | 10 | 10.0 |
Angiotensin II/*pharmacology | 2 | 1.0 |
Plasminogen Activator Inhibitor 1/*genetics | 3 | 8.0 |
Hela Cells/radiation effects | 2 | 28.0 |
Recombinant Fusion Proteins | 16 | 5.0 |
Tissue Plasminogen Activator/*genetics | 2 | 13.0 |
*Ultraviolet Rays | 3 | 1.0 |
Nuclear Proteins/physiology | 7 | 9.0 |
Proto-Oncogene Proteins c-myc/metabolism | 5 | 5.0 |
Transcription Factor AP-1/physiology | 5 | 11.0 |
Distamycins/*metabolism | 2 | 66.0 |
DNA-Binding Proteins/biosynthesis/genetics/*metabolism | 2 | 9.0 |
RNA, Messenger/analysis/metabolism | 2 | 1.0 |
DNA, Neoplasm/*genetics | 2 | 0.0 |
Carcinoma, Hepatocellular/metabolism/pathology | 2 | 14.0 |
Kidney/metabolism | 7 | 1.0 |
Androgens/*physiology | 3 | 6.0 |
Arachidonate 15-Lipoxygenase/*genetics | 2 | 66.0 |
Epithelial Cells/enzymology | 2 | 5.0 |
Prostate/*enzymology | 2 | 1.0 |
Aorta/*cytology | 2 | 18.0 |
Immediate-Early Proteins/*metabolism | 7 | 11.0 |
Oligonucleotides/chemistry | 9 | 7.0 |
Codon, Initiator | 5 | 13.0 |
DNA-Binding Proteins/*biosynthesis | 2 | 1.0 |
Protein Isoforms/biosynthesis | 2 | 11.0 |
Ubiquitin/metabolism | 2 | 0.0 |
Genome, Viral | 6 | 4.0 |
NF-kappa B/*genetics/*metabolism | 2 | 22.0 |
Proto-Oncogene Proteins/*genetics/*metabolism | 2 | 4.0 |
Keratin/*genetics | 4 | 6.0 |
Prospective Studies | 16 | 0.0 |
Liver/cytology/*metabolism | 3 | 4.0 |
Leukemia, Erythroblastic, Acute | 9 | 10.0 |
Substrate Specificity | 11 | 0.0 |
Estradiol/*pharmacology | 9 | 3.0 |
Receptors, Estrogen/genetics/*metabolism | 2 | 5.0 |
Dactinomycin/pharmacology | 3 | 0.0 |
Phorbol 12,13-Dibutyrate/pharmacology | 2 | 3.0 |
Sequence Deletion/genetics | 8 | 4.0 |
Breast Neoplasms/genetics/pathology | 2 | 5.0 |
Oligodeoxyribonucleotides | 59 | 7.0 |
Transforming Growth Factor alpha/*genetics | 2 | 4.0 |
*Cell Cycle | 5 | 2.0 |
Transcription Factor, Sp1/*genetics/*metabolism | 4 | 80.0 |
Endothelial Growth Factors/*pharmacology | 2 | 1.0 |
Lymphokines/*pharmacology | 2 | 0.0 |
Platelet-Derived Growth Factor/*pharmacology | 2 | 2.0 |
Glutathione Peroxidase/*genetics | 2 | 8.0 |
Oxidative Stress | 2 | 0.0 |
Microsatellite Repeats/*genetics | 2 | 0.0 |
Transcription Factor, Sp1/biosynthesis/genetics | 3 | 100.0 |
Adenoviridae/genetics | 7 | 1.0 |
Catalytic Domain/genetics | 2 | 3.0 |
Chromatography, Affinity | 11 | 1.0 |
Vimentin/*genetics | 2 | 16.0 |
Procollagen/*genetics | 3 | 2.0 |
Transcription Factor, Sp1/*metabolism/ultrastructure | 2 | 100.0 |
Interferon Type II/*pharmacology | 4 | 0.0 |
Trans-Activators | 4 | 9.0 |
Podophyllin/analogs & derivatives/metabolism | 3 | 100.0 |
Oligonucleotides/*metabolism | 2 | 40.0 |
Breast Neoplasms/genetics/*metabolism | 3 | 5.0 |
Receptors, Transforming Growth Factor beta/*biosynthesis/genetics | 2 | 50.0 |
Cyclic AMP/*metabolism | 8 | 3.0 |
Monosaccharide Transport Proteins/*genetics | 2 | 10.0 |
Heat | 5 | 0.0 |
RNA/analysis | 4 | 1.0 |
Genes, Structural/genetics | 7 | 2.0 |
Cyclic AMP/physiology | 4 | 3.0 |
Ferredoxins/*genetics | 2 | 50.0 |
Cattle/*genetics | 3 | 2.0 |
Up-Regulation/drug effects | 6 | 1.0 |
DNA Replication | 8 | 2.0 |
DNA, Viral/biosynthesis | 2 | 3.0 |
Haplorhini | 6 | 2.0 |
Phosphoprotein Phosphatase/*metabolism | 3 | 3.0 |
Glutamine | 6 | 13.0 |
Saccharomyces cerevisiae/genetics | 6 | 1.0 |
Sodium Channels/*genetics | 5 | 5.0 |
Polyribosomes/metabolism | 2 | 7.0 |
Transcription Factors/*biosynthesis/genetics | 3 | 3.0 |
T-Lymphocytes/physiology | 2 | 1.0 |
Tetradecanoylphorbol Acetate | 3 | 4.0 |
Receptor, IGF Type 1/*metabolism | 2 | 5.0 |
Minisatellite Repeats | 4 | 3.0 |
Proto-Oncogene Proteins c-jun/metabolism | 6 | 4.0 |
Interleukin-1/*pharmacology | 4 | 0.0 |
Endothelium, Vascular/enzymology | 2 | 4.0 |
Nitric-Oxide Synthase/biosynthesis/*genetics | 2 | 40.0 |
Promoter Regions (Genetics)/genetics/*physiology | 12 | 44.0 |
Cytomegalovirus/*metabolism | 2 | 18.0 |
Transcription Factors, TFII/*metabolism | 3 | 15.0 |
*Viral Proteins | 10 | 5.0 |
Genes, jun/genetics | 2 | 12.0 |
Mice, Mutant Strains | 2 | 0.0 |
Menstrual Cycle | 2 | 1.0 |
*Transcription, Genetic/drug effects | 8 | 7.0 |
Globins/*genetics | 22 | 18.0 |
*Genes, Retinoblastoma | 4 | 3.0 |
Drosophila/genetics | 10 | 7.0 |
Embryonic Development | 2 | 5.0 |
Heat-Shock Proteins 70/*genetics | 2 | 4.0 |
Capsid/*genetics | 3 | 15.0 |
Open Reading Frames/genetics | 3 | 2.0 |
*Physical Chromosome Mapping | 2 | 1.0 |
DNA Probes/genetics | 3 | 2.0 |
Enhancer Elements (Genetics)/genetics | 10 | 14.0 |
Tumor Necrosis Factor-alpha/*genetics | 4 | 1.0 |
Metalloproteins/genetics | 4 | 36.0 |
Oligonucleotides, Antisense/pharmacology | 4 | 1.0 |
Receptors, Cell Surface/*genetics/metabolism | 4 | 4.0 |
DNA/chemistry/*metabolism | 5 | 9.0 |
*Caveolins | 2 | 5.0 |
Estrogen Antagonists/pharmacology | 2 | 2.0 |
Tamoxifen/pharmacology | 2 | 2.0 |
Thymidylate Synthase/*genetics | 2 | 8.0 |
Fungal Proteins/genetics | 6 | 3.0 |
Lipoproteins/*genetics | 2 | 5.0 |
Alternative Splicing/*genetics | 3 | 1.0 |
Genes, Immediate-Early | 4 | 7.0 |
Herpesvirus 1, Human/*genetics/physiology | 2 | 18.0 |
Saccharomyces cerevisiae/genetics/metabolism | 3 | 2.0 |
Electrophoresis, Gel, Two-Dimensional | 4 | 1.0 |
*Glycoproteins | 20 | 2.0 |
Peptide Fragments/metabolism | 6 | 1.0 |
NF-kappa B/*antagonists & inhibitors | 2 | 4.0 |
Cell Cycle/radiation effects | 2 | 7.0 |
X-Rays | 2 | 1.0 |
Genome | 9 | 3.0 |
Histone Deacetylases/antagonists & inhibitors | 5 | 10.0 |
Mitochondrial ADP, ATP Translocases/*genetics | 3 | 37.0 |
Analysis of Variance | 3 | 0.0 |
France | 3 | 1.0 |
Treatment Outcome | 4 | 0.0 |
RNA Polymerase II/genetics | 2 | 28.0 |
Carrier Proteins/genetics | 4 | 1.0 |
Luminescent Proteins/genetics | 2 | 1.0 |
*Oncogenes | 7 | 1.0 |
Testis/metabolism | 2 | 0.0 |
DNA, Single-Stranded/metabolism | 3 | 4.0 |
*Genes, MDR | 3 | 8.0 |
Lymphocyte Activation/drug effects | 2 | 0.0 |
Trans-Activation (Genetics)/*genetics | 16 | 18.0 |
Astrocytoma | 3 | 8.0 |
*HIV-1 | 3 | 0.0 |
Cytomegalovirus/*genetics/metabolism | 2 | 50.0 |
HIV-1/genetics | 4 | 6.0 |
Terminal Repeat Sequences/genetics | 2 | 14.0 |
Cell Transformation, Neoplastic/genetics | 3 | 1.0 |
*DNA Replication | 7 | 2.0 |
DNA, Viral/*metabolism | 8 | 27.0 |
Base Composition | 32 | 12.0 |
L Cells (Cell Line) | 4 | 1.0 |
Tenascin/*genetics | 4 | 28.0 |
*Genes, src | 2 | 5.0 |
Hydrogen-Ion Concentration | 3 | 0.0 |
Skin/cytology/metabolism | 3 | 8.0 |
Receptors, Androgen/*metabolism | 2 | 1.0 |
*Zinc Fingers/genetics | 2 | 16.0 |
Electric Stimulation | 6 | 2.0 |
Electroencephalography | 3 | 1.0 |
Evoked Potentials, Somatosensory/*physiology | 4 | 14.0 |
Sural Nerve/*physiology | 3 | 50.0 |
RNA, Antisense | 2 | 3.0 |
Immediate-Early Proteins/metabolism | 2 | 6.0 |
Base Pairing | 3 | 5.0 |
*Heat-Shock Proteins 70 | 2 | 16.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/*metabolism | 5 | 6.0 |
Thrombin/*pharmacology | 2 | 1.0 |
*Receptors, Steroid | 3 | 14.0 |
Deoxyribonuclease I/*metabolism | 2 | 11.0 |
Embryonic and Fetal Development | 2 | 0.0 |
Amino Acid Substitution/genetics | 3 | 1.0 |
Endothelial Growth Factors/genetics | 2 | 2.0 |
*Ligases | 3 | 1.0 |
Lymphokines/genetics | 2 | 2.0 |
Repressor Proteins/chemistry/genetics/metabolism | 3 | 16.0 |
Recombinant Fusion Proteins/biosynthesis/metabolism | 4 | 4.0 |
Stomach Neoplasms | 4 | 12.0 |
*Evolution | 2 | 1.0 |
Translocation, Genetic | 3 | 0.0 |
Virus Replication/*physiology | 2 | 3.0 |
Lymphatic Metastasis | 4 | 0.0 |
Multivariate Analysis | 2 | 0.0 |
Odds Ratio | 2 | 0.0 |
Stomach/metabolism | 2 | 5.0 |
Stomach Neoplasms/*metabolism/*mortality | 2 | 100.0 |
Macrophages/*physiology | 2 | 2.0 |
Dichlororibofuranosylbenzimidazole/pharmacology | 3 | 11.0 |
Endothelium, Vascular/drug effects/metabolism | 2 | 3.0 |
Lysophosphatidylcholines/pharmacology | 2 | 11.0 |
Mitogen-Activated Protein Kinase Kinases/metabolism | 3 | 1.0 |
Nitric-Oxide Synthase/*metabolism | 2 | 2.0 |
Nucleic Acid Synthesis Inhibitors/pharmacology | 4 | 3.0 |
Melanoma/*genetics | 2 | 1.0 |
Phorbol Esters/pharmacology | 4 | 3.0 |
Stem Cell Factor/pharmacology/physiology | 2 | 66.0 |
gamma-Glutamyl Hydrolase/*genetics | 2 | 50.0 |
Chromosomes, Human, Pair 3/*genetics | 2 | 0.0 |
Protein Structure, Secondary | 3 | 0.0 |
Temperature | 3 | 0.0 |
Cerebral Cortex/*metabolism | 3 | 5.0 |
Cytosine/metabolism | 5 | 14.0 |
Templates, Genetic | 13 | 8.0 |
Chromosomes, Human, Pair 5/genetics | 2 | 2.0 |
Hybrid Cells | 10 | 0.0 |
Free Radicals | 2 | 1.0 |
Indicators and Reagents | 2 | 0.0 |
DNA, Viral/analysis | 2 | 0.0 |
HIV Antibodies/*blood | 2 | 5.0 |
Viral Proteins/*metabolism | 6 | 9.0 |
Cell Transformation, Viral | 5 | 1.0 |
Colony-Forming Units Assay | 2 | 0.0 |
Oncogene Proteins, Viral/*genetics | 9 | 15.0 |
Immunophenotyping | 2 | 0.0 |
Lymphocyte Activation | 6 | 0.0 |
Chorionic Villi Sampling | 2 | 4.0 |
Keratin/*biosynthesis | 2 | 20.0 |
Trophoblasts/cytology/*metabolism | 2 | 9.0 |
Cytokines/*genetics/metabolism | 2 | 12.0 |
Cytochromes c1/*genetics | 3 | 75.0 |
*DNA Damage | 2 | 0.0 |
Tetrahydrofolate Dehydrogenase/genetics | 4 | 4.0 |
Thymidine Kinase/*genetics | 4 | 8.0 |
Polymorphism, Restriction Fragment Length | 11 | 0.0 |
*5' Untranslated Regions | 3 | 11.0 |
Viral Envelope Proteins/*genetics | 2 | 6.0 |
Proto-Oncogene Proteins/*genetics | 13 | 1.0 |
Integrin alphaV | 2 | 7.0 |
Nuclear Proteins/analysis | 9 | 5.0 |
Cyclin-Dependent Kinases/*metabolism | 2 | 0.0 |
Cell Extracts/chemistry | 3 | 12.0 |
Nucleic Acid Heteroduplexes | 2 | 4.0 |
Oligonucleotides/chemical synthesis/metabolism | 2 | 66.0 |
Epithelial Cells/*virology | 2 | 28.0 |
Choriocarcinoma | 2 | 5.0 |
Placenta/pathology | 3 | 25.0 |
Antibodies, Monoclonal | 4 | 0.0 |
Immunization | 2 | 0.0 |
*Linkage (Genetics) | 2 | 0.0 |
Membrane Proteins/genetics | 2 | 0.0 |
*X Chromosome | 7 | 0.0 |
Drosophila melanogaster/cytology | 4 | 57.0 |
Guanine/metabolism | 2 | 11.0 |
Transcription Factor, Sp1/genetics/*metabolism/physiology | 2 | 100.0 |
Erythrocytes/*metabolism | 2 | 0.0 |
Globins/biosynthesis/*genetics | 2 | 15.0 |
Leukemia, Experimental | 3 | 20.0 |
Phosphoproteins/metabolism | 6 | 0.0 |
*Adaptor Proteins, Signal Transducing | 2 | 0.0 |
Heat-Shock Proteins/*genetics | 7 | 10.0 |
Peptide Chain Initiation, Translational/genetics | 2 | 25.0 |
Receptors, Estrogen/*genetics | 2 | 2.0 |
Podophyllin/*analogs & derivatives/metabolism | 2 | 50.0 |
Repressor Proteins/physiology | 3 | 8.0 |
Proton-Translocating ATPases/*genetics | 3 | 25.0 |
Suppression, Genetic | 5 | 7.0 |
Conserved Sequence/*genetics | 4 | 6.0 |
DNA-Binding Proteins/chemistry/genetics/metabolism | 2 | 6.0 |
Gastrins/genetics | 3 | 60.0 |
Ornithine Decarboxylase/*genetics | 5 | 45.0 |
Sheep | 3 | 0.0 |
Transcription Factors/metabolism/*pharmacology | 3 | 27.0 |
Deoxyribonuclease I/pharmacology | 3 | 16.0 |
Arachidonate 12-Lipoxygenase/*genetics/metabolism | 2 | 100.0 |
Genes, fos/*genetics | 2 | 10.0 |
Haplotypes | 4 | 0.0 |
Enzyme Repression | 2 | 10.0 |
RNA, Messenger/isolation & purification | 2 | 2.0 |
Transforming Growth Factor alpha/*pharmacology | 2 | 3.0 |
Virus Replication/*genetics | 3 | 9.0 |
Repressor Proteins/genetics/*metabolism | 7 | 3.0 |
Connexin 43/*genetics | 2 | 28.0 |
Genes, fos | 5 | 4.0 |
Myometrium/*metabolism | 2 | 7.0 |
Cross-Sectional Studies | 2 | 0.0 |
Pregnancy-Specific beta 1-Glycoproteins/*analysis | 119 | 99.0 |
Prenatal Diagnosis/*methods | 7 | 5.0 |
Down Syndrome/*diagnosis | 2 | 6.0 |
Pregnancy Trimester, First/*blood | 2 | 33.0 |
Promoter Regions (Genetics)/immunology | 2 | 2.0 |
Azacitidine/analogs & derivatives/pharmacology | 2 | 8.0 |
Promoter Regions (Genetics)/*genetics/physiology | 4 | 36.0 |
Liver/chemistry | 2 | 2.0 |
Liver Neoplasms, Experimental/metabolism/pathology | 2 | 40.0 |
G0 Phase | 3 | 4.0 |
Animals, Newborn | 6 | 1.0 |
Carbohydrate Sequence | 2 | 0.0 |
Proteins/chemistry/*genetics | 2 | 1.0 |
Embryo/metabolism | 2 | 1.0 |
Fatty Acid Synthetase Complex/genetics | 2 | 100.0 |
Mutagenesis/genetics | 2 | 5.0 |
Recombinant Proteins/genetics | 4 | 3.0 |
Nephroblastoma/genetics | 2 | 3.0 |
Repressor Proteins/chemistry/genetics/*metabolism | 2 | 4.0 |
Trans-Activators/chemistry/genetics/*metabolism | 2 | 2.0 |
Chromatography, Affinity/methods | 3 | 4.0 |
DNA, Complementary/isolation & purification | 2 | 1.0 |
Transcription Factors/chemistry/*genetics | 2 | 2.0 |
Up-Regulation/*genetics | 2 | 8.0 |
Zinc Fingers/*genetics | 9 | 4.0 |
Platelet-Derived Growth Factor/*genetics | 5 | 15.0 |
Cyclins/*genetics/metabolism | 7 | 15.0 |
Cytoplasm/metabolism | 3 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 4 | 0.0 |
Transcription Factor, Sp1/*chemistry/metabolism | 3 | 100.0 |
Keratinocytes/*physiology | 2 | 5.0 |
Immunosorbent Techniques | 6 | 2.0 |
Megakaryocytes/*metabolism | 3 | 9.0 |
Subcellular Fractions/metabolism | 3 | 0.0 |
DNA-Binding Proteins/analysis | 5 | 6.0 |
Ion Channels/biosynthesis/*genetics | 2 | 66.0 |
Chromatin/*physiology | 3 | 23.0 |
Receptors, LDL/genetics | 3 | 4.0 |
Transcription Factors/chemistry/metabolism | 3 | 11.0 |
Terminal Repeat Sequences | 2 | 6.0 |
Viral Envelope Proteins/genetics | 2 | 8.0 |
*Pseudogenes | 7 | 4.0 |
Biological Markers/*blood | 3 | 1.0 |
Chorionic Gonadotropin/blood | 28 | 28.0 |
Gestational Age | 25 | 2.0 |
Pregnancy-Associated Plasma Protein-A/analysis | 14 | 77.0 |
Pregnancy-Specific beta 1-Glycoproteins/analysis | 34 | 97.0 |
*Prenatal Diagnosis | 5 | 1.0 |
Ultrasonography, Prenatal | 4 | 6.0 |
Uterine Neoplasms/*diagnosis | 2 | 50.0 |
Genes, Insect | 2 | 3.0 |
NF-kappa B/genetics | 4 | 11.0 |
Alternative Splicing/genetics | 4 | 2.0 |
Brain/embryology | 3 | 6.0 |
Vascular Endothelial Growth Factor A/*genetics | 2 | 4.0 |
Daunorubicin/*analogs & derivatives/*pharmacology | 2 | 100.0 |
Transcription Factor, Sp1/*antagonists & inhibitors/metabolism | 3 | 100.0 |
Fetus | 9 | 1.0 |
Alkaline Phosphatase/*genetics | 3 | 15.0 |
Antibodies, Anti-Idiotypic | 2 | 9.0 |
Recombinant Proteins/chemistry/genetics/metabolism | 3 | 0.0 |
Transcription Factor, Sp1/chemistry/genetics/*metabolism | 7 | 100.0 |
*Genes, Homeobox | 2 | 0.0 |
G2 Phase | 3 | 1.0 |
Blood Proteins/metabolism | 4 | 1.0 |
Retinoblastoma Protein/metabolism | 7 | 1.0 |
RNA Polymerase II/*metabolism | 10 | 10.0 |
Actins/*genetics | 4 | 6.0 |
*Helix-Loop-Helix Motifs | 3 | 3.0 |
Muscle, Skeletal/*metabolism | 2 | 1.0 |
MyoD Protein/metabolism | 2 | 10.0 |
Serum Response Factor | 7 | 6.0 |
Antigens, CD95/*genetics | 3 | 10.0 |
Antigens, Surface/*genetics | 2 | 3.0 |
Microtubule-Associated Proteins/*genetics | 2 | 3.0 |
Regulatory Sequences, Nucleic Acid/*genetics | 13 | 13.0 |
Yeasts/genetics | 2 | 2.0 |
Azacitidine/pharmacology | 2 | 4.0 |
Endothelium, Vascular/cytology/metabolism | 2 | 1.0 |
Sulfites/pharmacology | 2 | 6.0 |
Abortion, Spontaneous/*blood | 2 | 28.0 |
Pregnancy-Specific beta 1-Glycoproteins/*metabolism | 19 | 95.0 |
Drosophila/genetics/metabolism | 3 | 30.0 |
Genes, Regulator/*genetics | 7 | 17.0 |
Electromyography | 5 | 2.0 |
Cell Cycle Proteins/genetics/metabolism | 2 | 2.0 |
Helix-Loop-Helix Motifs/genetics | 2 | 5.0 |
Retinoblastoma Protein/*metabolism | 4 | 2.0 |
Ionomycin/pharmacology | 2 | 0.0 |
Mitogens/pharmacology | 2 | 0.0 |
T-Lymphocytes/drug effects | 2 | 3.0 |
Okadaic Acid/pharmacology | 4 | 4.0 |
Fungal Proteins/genetics/metabolism | 2 | 2.0 |
Oligonucleotides/pharmacology | 6 | 17.0 |
Proto-Oncogene Proteins c-myb | 2 | 3.0 |
Gene Products, tax/metabolism | 3 | 27.0 |
Proteins/*genetics/metabolism | 3 | 1.0 |
Transformation, Genetic | 2 | 1.0 |
*Genes, Regulator | 7 | 6.0 |
Nucleosomes/physiology | 3 | 100.0 |
Polymorphism, Single-Stranded Conformational | 5 | 0.0 |
Cyclin D1/genetics/*metabolism | 2 | 10.0 |
Spodoptera | 4 | 1.0 |
*TATA Box | 12 | 11.0 |
Kidney/cytology/metabolism | 2 | 2.0 |
Transcription Factor, Sp1/biosynthesis/*metabolism | 5 | 100.0 |
Apolipoproteins C/*genetics/metabolism | 3 | 42.0 |
Liver | 4 | 7.0 |
Proteins/genetics | 3 | 0.0 |
*Apoptosis/drug effects | 2 | 1.0 |
Zinc/*metabolism | 4 | 6.0 |
Neoplasm Proteins/biosynthesis/*genetics | 3 | 3.0 |
Proto-Oncogene Proteins c-bcl-2/biosynthesis/*genetics | 2 | 66.0 |
Alcohol Dehydrogenase/*genetics | 4 | 4.0 |
Aldehyde Oxidoreductases/*genetics | 2 | 11.0 |
Cell Differentiation/drug effects/genetics | 6 | 10.0 |
Okadaic Acid/*pharmacology | 2 | 20.0 |
RNA, Messenger/drug effects/metabolism | 4 | 2.0 |
Phosphoproteins/physiology | 2 | 3.0 |
Signal Transduction/genetics | 3 | 1.0 |
Stomach Neoplasms/*genetics/metabolism | 2 | 7.0 |
Chorionic Gonadotropin/pharmacology | 3 | 2.0 |
Adenine | 2 | 3.0 |
Asthma/*genetics | 3 | 5.0 |
T-Lymphocytes/immunology | 2 | 0.0 |
Thymine | 2 | 3.0 |
Transforming Growth Factor beta/*genetics | 2 | 2.0 |
Organ Specificity/genetics | 8 | 5.0 |
Regulatory Sequences, Nucleic Acid/genetics/physiology | 3 | 33.0 |
HIV-1/genetics/*physiology | 2 | 1.0 |
Herpesvirus 6, Human/*physiology | 2 | 20.0 |
Endodeoxyribonucleases/*genetics | 4 | 20.0 |
*Escherichia coli Proteins | 2 | 0.0 |
Transfection/genetics | 8 | 5.0 |
Down Syndrome/blood/*diagnosis | 3 | 23.0 |
Macrophages | 2 | 2.0 |
Protein-Tyrosine Kinase/*biosynthesis/*genetics | 2 | 40.0 |
DNA Repair | 5 | 0.0 |
*Genes, Viral | 9 | 4.0 |
Virus Replication/genetics | 4 | 8.0 |
Neoplasm Proteins/*metabolism | 3 | 0.0 |
Genes, Regulator/physiology | 2 | 20.0 |
Antibody Affinity | 2 | 1.0 |
*Epitopes | 2 | 1.0 |
Chloramphenicol O-Acetyltransferase | 2 | 5.0 |
Huntington Disease/*genetics | 2 | 4.0 |
Cross-Linking Reagents | 5 | 1.0 |
DNA Repair/*genetics | 3 | 0.0 |
Embryo Implantation | 4 | 11.0 |
Estradiol/blood | 6 | 1.0 |
Fertilization in Vitro | 3 | 2.0 |
Glycoproteins/*blood | 9 | 12.0 |
Menotropins/therapeutic use | 2 | 14.0 |
Ovulation | 2 | 3.0 |
Pregnancy Proteins/*blood | 47 | 74.0 |
Progesterone/blood | 10 | 4.0 |
Nucleic Acid Hybridization | 14 | 0.0 |
Acetylcholinesterase/*genetics | 2 | 10.0 |
Nuclear Proteins/*pharmacology | 2 | 18.0 |
8-Bromo Cyclic Adenosine Monophosphate/pharmacology | 2 | 2.0 |
Cyclic AMP-Dependent Protein Kinases/*metabolism | 3 | 3.0 |
Proteoglycans/*genetics | 4 | 7.0 |
Cyclins/*biosynthesis/genetics | 2 | 5.0 |
Protein Synthesis Inhibitors/*pharmacology | 2 | 6.0 |
Methyltransferases/*genetics | 3 | 2.0 |
*Genes, ras | 7 | 3.0 |
DNA, Viral/metabolism | 12 | 13.0 |
Immediate-Early Proteins/genetics | 3 | 6.0 |
Papio | 5 | 3.0 |
Down-Regulation/genetics | 2 | 3.0 |
Retinoblastoma Protein/*physiology | 4 | 12.0 |
HIV Long Terminal Repeat/genetics | 8 | 17.0 |
Phleomycins/pharmacology | 2 | 100.0 |
Hematopoietic Stem Cells/metabolism | 2 | 1.0 |
Recombinant Fusion Proteins/biosynthesis/genetics | 2 | 2.0 |
Glioma | 3 | 4.0 |
Neuroblastoma | 5 | 2.0 |
Transcription, Genetic/*drug effects/genetics | 2 | 33.0 |
Proto-Oncogene Proteins c-jun/*physiology | 3 | 13.0 |
Interleukin-2/*genetics | 2 | 3.0 |
Endothelial Growth Factors/*genetics | 2 | 1.0 |
Lymphokines/*genetics | 2 | 0.0 |
*Immunotherapy | 2 | 1.0 |
DNA/*genetics/*metabolism | 4 | 30.0 |
Erythrocytes/metabolism | 5 | 2.0 |
In Situ Hybridization | 7 | 0.0 |
*Embryo Transfer | 5 | 20.0 |
Endometrium/*pathology | 2 | 10.0 |
*Fertilization in Vitro | 7 | 6.0 |
Pregnancy-Specific beta 1-Glycoproteins/analysis/*metabolism | 2 | 100.0 |
*Chromosomes, Human, Pair 17 | 2 | 0.0 |
Rats/*genetics | 3 | 5.0 |
Human T-lymphotropic virus 1/*genetics/metabolism | 2 | 33.0 |
Isoenzymes | 2 | 1.0 |
L-Lactate Dehydrogenase/*genetics | 2 | 14.0 |
Fetus/metabolism | 2 | 1.0 |
Osteoblasts/*metabolism | 2 | 3.0 |
Brain/enzymology | 2 | 1.0 |
*Genes, Structural | 27 | 3.0 |
Chloramphenicol O-Acetyltransferase/biosynthesis | 21 | 14.0 |
*Chromosomal Proteins, Non-Histone | 3 | 1.0 |
DNA-Binding Proteins/biosynthesis/*metabolism | 7 | 11.0 |
African Continental Ancestry Group/*genetics | 2 | 0.0 |
Blood Grouping and Crossmatching | 2 | 2.0 |
United States | 3 | 0.0 |
HIV-1/*genetics/metabolism | 4 | 14.0 |
Gene Expression Regulation, Viral/*genetics | 2 | 12.0 |
Trans-Activation (Genetics)/genetics | 4 | 4.0 |
Protein Binding/physiology | 2 | 0.0 |
Peptide Elongation Factor 1 | 2 | 15.0 |
*Aquaporins | 3 | 3.0 |
Ion Channels/*genetics | 2 | 4.0 |
Receptor Protein-Tyrosine Kinases/*genetics | 3 | 0.0 |
Receptors, Vascular Endothelial Growth Factor | 2 | 0.0 |
Transcription Factor, Sp1/*chemistry/genetics/*metabolism | 2 | 100.0 |
Gene Products, gag/metabolism | 2 | 15.0 |
Muridae | 4 | 3.0 |
Trinucleotide Repeats | 2 | 1.0 |
Oligonucleotide Probes/genetics | 5 | 4.0 |
Antigens, Surface/immunology | 2 | 1.0 |
Erythropoietin/*physiology | 2 | 8.0 |
Receptors, Erythropoietin/*genetics | 2 | 7.0 |
5-Aminolevulinate Synthetase/*genetics/metabolism | 2 | 100.0 |
DNA-Binding Proteins/isolation & purification/*metabolism | 5 | 7.0 |
Gene Expression Regulation, Developmental/*genetics | 2 | 2.0 |
Transcription Factors/isolation & purification/*metabolism | 6 | 11.0 |
Cell Aging | 3 | 3.0 |
Insulin-Like Growth Factor II/genetics | 2 | 2.0 |
Receptors, Estrogen/*analysis | 3 | 1.0 |
Transcobalamins/*genetics | 2 | 15.0 |
*Receptors, Cell Surface | 5 | 1.0 |
Estrogens | 2 | 8.0 |
Neoplasms, Hormone-Dependent/pathology | 2 | 28.0 |
DNA-Binding Proteins/*chemistry | 3 | 4.0 |
Calcineurin/metabolism | 2 | 8.0 |
Gene Expression Regulation, Enzymologic/*genetics | 3 | 5.0 |
Phosphoprotein Phosphatase/metabolism | 3 | 4.0 |
Folic Acid/*metabolism | 3 | 6.0 |
Arteriosclerosis/genetics | 2 | 6.0 |
Carcinoma, Hepatocellular/*metabolism/pathology | 3 | 4.0 |
Liver Neoplasms/*metabolism/pathology | 3 | 4.0 |
Progesterone/*pharmacology | 2 | 2.0 |
DNA-Binding Proteins/*metabolism/physiology | 2 | 5.0 |
Neurons/cytology/*metabolism | 3 | 3.0 |
Transcription Factors/*metabolism/physiology | 3 | 17.0 |
Cornea/cytology/*metabolism | 2 | 16.0 |
*Protein Biosynthesis | 5 | 1.0 |
Recombinant Proteins/biosynthesis/metabolism | 3 | 1.0 |
Luciferases/biosynthesis | 10 | 11.0 |
Muscle, Smooth, Vascular/*cytology | 2 | 9.0 |
Transcription Factors/biosynthesis/*metabolism | 5 | 11.0 |
Umbilical Veins | 6 | 1.0 |
Computational Biology | 2 | 1.0 |
DNA-Directed DNA Polymerase/*genetics | 3 | 10.0 |
NIH 3T3 Cells | 3 | 1.0 |
Neurons/cytology | 2 | 4.0 |
*Chromosomes, Human, Pair 6 | 3 | 1.0 |
Aspergillus Nuclease S1 | 4 | 12.0 |
Ribonucleases | 2 | 4.0 |
Transcription Factor, Sp1/*biosynthesis/genetics | 3 | 75.0 |
Gene Products, tat/metabolism | 5 | 13.0 |
Amanitins/pharmacology | 2 | 12.0 |
Transcription Factors/analysis/*metabolism | 2 | 20.0 |
Genes, Viral | 8 | 3.0 |
*Virus Replication | 5 | 1.0 |
Adaptor Protein Complex alpha Subunits | 3 | 6.0 |
Adaptor Proteins, Vesicular Transport | 3 | 4.0 |
Estrogens/pharmacology | 2 | 2.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Cell Nucleus/*enzymology | 3 | 7.0 |
Membrane Proteins/*genetics/metabolism | 2 | 1.0 |
Megakaryocytes/*physiology | 2 | 11.0 |
Platelet Glycoprotein GPIIb-IIIa Complex/*genetics | 2 | 25.0 |
Butyric Acid | 2 | 4.0 |
Leukemia, Erythroblastic, Acute/*genetics/metabolism | 2 | 66.0 |
Keratin/metabolism | 3 | 2.0 |
Placental Lactogen/metabolism | 7 | 41.0 |
Genes, Structural | 27 | 3.0 |
Genes, tat | 2 | 7.0 |
Detergents/pharmacology | 2 | 1.0 |
Proteins/genetics/metabolism | 2 | 1.0 |
Gene Products, tat/genetics/*metabolism | 4 | 9.0 |
Na(+)-K(+)-Exchanging ATPase/*biosynthesis/*genetics | 2 | 100.0 |
Mice, SCID | 3 | 0.0 |
Protein-Serine-Threonine Kinases/*physiology | 2 | 1.0 |
*Protein-Tyrosine Kinase | 2 | 0.0 |
Sarcoma Viruses, Avian/genetics | 2 | 10.0 |
*Proto-Oncogenes | 9 | 1.0 |
Neoplasm Staging | 4 | 0.0 |
*Trophoblasts | 2 | 50.0 |
Tumor Markers, Biological/*blood | 6 | 1.0 |
Testis/*metabolism | 2 | 2.0 |
*Carbon-Oxygen Lyases | 3 | 15.0 |
*DNA-(Apurinic or Apyrimidinic Site) Lyase | 3 | 7.0 |
Exodeoxyribonucleases/*genetics | 2 | 15.0 |
Cell Nucleus | 3 | 3.0 |
*Aminoglycosides | 2 | 7.0 |
Anti-Bacterial Agents/*metabolism/pharmacology | 2 | 28.0 |
Insulin-Like Growth Factor I/*pharmacology | 3 | 2.0 |
Osteosarcoma/*metabolism | 2 | 14.0 |
DNA-Binding Proteins/analysis/metabolism | 2 | 9.0 |
Insulin-Like Growth Factor I/*genetics | 2 | 8.0 |
Adipocytes/metabolism | 2 | 4.0 |
Leptin | 2 | 1.0 |
NF-kappa B/genetics/*metabolism | 4 | 5.0 |
Oligodeoxyribonucleotides/*metabolism | 3 | 25.0 |
DNA/*chemistry/metabolism | 2 | 8.0 |
Cell Cycle/*genetics | 3 | 4.0 |
cdc25 Phosphatase | 2 | 4.0 |
*Apoptosis | 2 | 0.0 |
DNA-Binding Proteins/*genetics/*physiology | 3 | 8.0 |
Blood Proteins/*genetics | 3 | 1.0 |
Rh-Hr Blood-Group System/*genetics | 2 | 2.0 |
Monocytes/*physiology | 3 | 1.0 |
*Antigens, Nuclear | 2 | 1.0 |
Nuclear Proteins/isolation & purification/*metabolism | 3 | 10.0 |
Blood Proteins/*metabolism | 3 | 1.0 |
Mitogen-Activated Protein Kinases/genetics/*metabolism | 2 | 4.0 |
Drosophila/cytology/genetics | 4 | 100.0 |
Recombinant Proteins/biosynthesis/chemistry | 2 | 2.0 |
Baculoviridae/genetics | 2 | 1.0 |
*HIV Long Terminal Repeat/drug effects | 2 | 100.0 |
Histones/*genetics | 5 | 17.0 |
Spermatocytes/metabolism | 2 | 11.0 |
Phytohemagglutinins/pharmacology | 2 | 0.0 |
Follow-Up Studies | 4 | 0.0 |
Survivors | 2 | 2.0 |
Poly(ADP-ribose) Polymerases/chemistry/*genetics | 2 | 100.0 |
Integrin alpha6 | 2 | 10.0 |
Cytomegalovirus/*genetics/*metabolism | 2 | 40.0 |
*Genes, pol | 2 | 50.0 |
Immediate-Early Proteins/*genetics/*metabolism | 2 | 33.0 |
Placenta/*physiology | 2 | 7.0 |
DNA, Neoplasm/analysis | 2 | 0.0 |
DNA-Binding Proteins/*biosynthesis/genetics | 2 | 2.0 |
Drosophila melanogaster/genetics | 5 | 5.0 |
RNA, Messenger/biosynthesis/drug effects | 2 | 3.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 2 | 0.0 |
Intestines/metabolism | 2 | 1.0 |
Plicamycin/*analogs & derivatives/*pharmacology | 2 | 50.0 |
Lysosomes/enzymology | 2 | 3.0 |
Protein Kinases/*genetics | 2 | 1.0 |
Insulin/metabolism | 3 | 2.0 |
DNA-Binding Proteins/chemistry/*genetics/metabolism | 2 | 4.0 |
Transcription Factors/chemistry/*genetics/metabolism | 2 | 4.0 |
*Growth Inhibitors | 2 | 3.0 |
*Recombination, Genetic | 2 | 0.0 |
Repetitive Sequences, Nucleic Acid/*genetics | 3 | 2.0 |
Chromosomes, Human, Pair 19/genetics | 2 | 1.0 |
Peptides/*genetics | 3 | 3.0 |
Lymphocytes/metabolism | 2 | 0.0 |
Cysteine Endopeptidases/*metabolism | 2 | 0.0 |
Cytosol/metabolism | 3 | 0.0 |
Culture Media | 6 | 0.0 |
Gene Products, tax/*metabolism | 6 | 18.0 |
Human T-lymphotropic virus 1/*metabolism | 2 | 10.0 |
Platelet-Derived Growth Factor/*biosynthesis/genetics | 3 | 75.0 |
Proto-Oncogene Proteins/*biosynthesis/genetics | 2 | 2.0 |
Proto-Oncogene Proteins c-sis | 4 | 17.0 |
Collagen/*biosynthesis/*genetics | 3 | 25.0 |
Carcinoembryonic Antigen/*analysis | 7 | 12.0 |
Chorionic Gonadotropin/*analysis | 13 | 37.0 |
Neoplasm Proteins/*analysis | 3 | 0.0 |
Radioimmunoassay | 50 | 2.0 |
Tumor Markers, Biological/*analysis | 4 | 0.0 |
Protein Precursors/genetics | 4 | 4.0 |
HIV/*genetics | 4 | 6.0 |
Phospholipase C/*genetics | 2 | 15.0 |
Gene Expression Regulation, Enzymologic/genetics | 3 | 4.0 |
Leukemia | 2 | 2.0 |
Chimeric Proteins/metabolism | 3 | 1.0 |
T-Lymphocytes/metabolism | 5 | 1.0 |
RNA Interference | 4 | 1.0 |
RNA, Small Interfering/metabolism | 3 | 1.0 |
Bacteriophage lambda/genetics | 4 | 8.0 |
Chromosomes, Human, Pair 1 | 2 | 0.0 |
Keratinocytes/cytology/metabolism | 2 | 7.0 |
Apoptosis/genetics | 2 | 0.0 |
Integrin alphaXbeta2/*genetics | 3 | 100.0 |
Leukocytes/*immunology | 2 | 1.0 |
Masseter Muscle/*physiology | 2 | 66.0 |
Parathyroid Hormone-Related Protein | 4 | 4.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
Peptide Mapping | 2 | 0.0 |
Receptors, Retinoic Acid/genetics/metabolism | 2 | 6.0 |
Fatty Acid Synthetase Complex/*genetics | 2 | 22.0 |
Collagen/*genetics/metabolism | 2 | 5.0 |
Retroviridae Proteins, Oncogenic/genetics | 2 | 14.0 |
Genes, Retinoblastoma/*genetics | 3 | 7.0 |
Platelet-Derived Growth Factor/biosynthesis/*genetics | 2 | 50.0 |
Recombination, Genetic | 7 | 0.0 |
*Repetitive Sequences, Nucleic Acid | 13 | 3.0 |
Antigens, CD/*biosynthesis/genetics | 2 | 3.0 |
Nucleosomes/*metabolism | 5 | 14.0 |
Xenopus laevis | 3 | 0.0 |
Chromosomes, Human, Pair 11 | 2 | 0.0 |
Endothelium, Vascular/*physiology | 2 | 1.0 |
Immunologic Techniques | 3 | 0.0 |
*Neovascularization, Physiologic | 3 | 1.0 |
Receptors, Interleukin-2/*genetics | 3 | 11.0 |
Thromboplastin/*genetics | 4 | 13.0 |
Transgenes | 2 | 0.0 |
Protease Inhibitors/pharmacology | 2 | 0.0 |
Bacteriophage lambda | 2 | 14.0 |
Peptide Chain Initiation, Translational | 3 | 6.0 |
Acyl-CoA Dehydrogenase | 2 | 9.0 |
Glycolysis | 2 | 3.0 |
Myocardium/*metabolism | 4 | 1.0 |
Transcription Factor, Sp1/biosynthesis/*genetics | 2 | 100.0 |
Transcription Factors/biosynthesis/*genetics | 3 | 2.0 |
Receptors, Cytoplasmic and Nuclear/*physiology | 3 | 5.0 |
Phosphoproteins/genetics/*metabolism | 2 | 1.0 |
Proto-Oncogenes | 2 | 1.0 |
Simplexvirus/genetics | 3 | 13.0 |
Drug Resistance, Multiple/*genetics | 2 | 3.0 |
Neoplasms/genetics | 3 | 2.0 |
Glycoproteins/biosynthesis/*genetics | 2 | 25.0 |
Tissue Inhibitor of Metalloproteinases | 2 | 3.0 |
Quinolines/*pharmacology | 2 | 6.0 |
Virus Replication/*drug effects | 2 | 1.0 |
Cytomegalovirus/*genetics | 3 | 8.0 |
DNA, Viral/genetics | 8 | 5.0 |
Dependovirus/*genetics | 3 | 3.0 |
Viral Proteins/genetics | 2 | 3.0 |
Fungal Proteins/*metabolism | 2 | 2.0 |
Fatty Acid Synthetase Complex/*biosynthesis/genetics | 2 | 100.0 |
RNA Processing, Post-Transcriptional | 2 | 1.0 |
Nucleosomes/metabolism | 4 | 8.0 |
*Phosphoproteins | 3 | 2.0 |
Antibodies/immunology/metabolism | 2 | 11.0 |
*Chromosomes, Human, Pair 11 | 2 | 0.0 |
Collagen/biosynthesis/*genetics | 2 | 6.0 |
Cysteine Proteinase Inhibitors/pharmacology | 2 | 0.0 |
*Endopeptidases | 2 | 6.0 |
Zinc Fingers/genetics/*physiology | 2 | 10.0 |
Antineoplastic Agents/pharmacology | 10 | 1.0 |
Gene Silencing | 4 | 1.0 |
Receptor Protein-Tyrosine Kinases/*genetics/metabolism | 2 | 3.0 |
Carcinoma, Hepatocellular/*genetics | 2 | 2.0 |
Epithelium | 3 | 5.0 |
Endothelium, Vascular/*enzymology | 5 | 10.0 |
Melanoma | 3 | 3.0 |
Neoplasm Proteins/*genetics | 8 | 0.0 |
T-Lymphocytes/*immunology | 3 | 0.0 |
Thromboplastin/*genetics/metabolism | 2 | 25.0 |
Genes/*genetics | 2 | 4.0 |
Homeodomain Proteins/metabolism | 2 | 2.0 |
Proto-Oncogene Proteins c-rel | 5 | 8.0 |
Pregnancy Trimester, Second | 12 | 5.0 |
Hela Cells/metabolism | 21 | 13.0 |
Age Factors | 5 | 0.0 |
*Down-Regulation | 5 | 1.0 |
*Neovascularization, Pathologic | 2 | 0.0 |
Perfusion | 2 | 0.0 |
Vascular Endothelial Growth Factor A/metabolism | 2 | 1.0 |
Estradiol/*blood | 4 | 2.0 |
*Infant, Small for Gestational Age | 2 | 11.0 |
Placental Lactogen/*blood | 21 | 67.0 |
*Nucleic Acid Conformation | 3 | 3.0 |
Gene Rearrangement | 2 | 0.0 |
Mice, Nude | 10 | 0.0 |
Proto-Oncogenes/*genetics | 2 | 2.0 |
DNA, Recombinant | 6 | 3.0 |
Isoenzymes/*genetics/metabolism | 3 | 5.0 |
Molecular Mimicry | 2 | 2.0 |
Calcitriol/*pharmacology | 2 | 1.0 |
Drug Resistance | 3 | 0.0 |
Embryo/cytology | 2 | 2.0 |
Peptides/pharmacology | 2 | 1.0 |
Receptors, Glucocorticoid/genetics/metabolism | 3 | 21.0 |
Proto-Oncogene Protein c-met/*genetics/metabolism | 2 | 28.0 |
Placenta/*metabolism | 7 | 4.0 |
Progesterone/*blood | 6 | 15.0 |
DNA/*genetics | 6 | 1.0 |
RNA Splicing | 12 | 2.0 |
Elastin/*genetics | 2 | 7.0 |
Retinoblastoma/*genetics | 2 | 3.0 |
Recombinant Proteins | 5 | 0.0 |
Breast | 2 | 6.0 |
Brain Chemistry | 3 | 1.0 |
Chromosomes, Human, Pair 16 | 2 | 1.0 |
Tissue Inhibitor of Metalloproteinase-2 | 2 | 7.0 |
Drosophila/*genetics | 2 | 6.0 |
Afferent Pathways/physiology | 2 | 10.0 |
Keratin/genetics | 2 | 4.0 |
Tetrahydrofolate Dehydrogenase/*genetics | 8 | 6.0 |
*Lymphocyte Activation | 2 | 0.0 |
T-Lymphocytes/*physiology | 3 | 1.0 |
Isomerases/*genetics | 3 | 20.0 |
Adaptor Protein Complex 2 | 2 | 22.0 |
*Genes | 6 | 2.0 |
Luteinizing Hormone/*genetics/metabolism | 2 | 66.0 |
Receptors, Tumor Necrosis Factor/*genetics | 2 | 3.0 |
*Chromosomes, Human, Pair 12 | 3 | 1.0 |
Acute Disease | 4 | 0.0 |
Liver/*enzymology | 5 | 1.0 |
Sex Characteristics | 2 | 0.0 |
Mice/*genetics | 4 | 1.0 |
Blood | 2 | 1.0 |
Membrane Potentials/drug effects | 2 | 1.0 |
Doxorubicin/pharmacology | 4 | 1.0 |
Colonic Neoplasms/genetics/*metabolism/pathology | 2 | 18.0 |
G1 Phase/drug effects | 2 | 1.0 |
Protein Transport | 3 | 0.0 |
Antioxidants/pharmacology | 2 | 1.0 |
DNA-Binding Proteins/chemistry/physiology | 2 | 22.0 |
Leydig Cells/*enzymology | 2 | 40.0 |
Deoxyribonucleases, Type II Site-Specific/metabolism | 3 | 1.0 |
Hormones/pharmacology | 2 | 4.0 |
RNA, Small Nuclear/*genetics | 4 | 14.0 |
Antigens, Viral/*immunology | 2 | 2.0 |
Epstein-Barr Virus Nuclear Antigens | 5 | 11.0 |
Retroviridae/*genetics | 3 | 2.0 |
Hela Cells/physiology | 3 | 13.0 |
Mice, Inbred ICR | 2 | 0.0 |
Pregnancy-Specific beta 1-Glycoproteins/analysis/*secretion | 2 | 100.0 |
Butyrates/pharmacology | 2 | 5.0 |
HIV-1/metabolism | 2 | 4.0 |
Colonic Neoplasms/genetics | 2 | 3.0 |
Neutrophils/metabolism | 2 | 1.0 |
*Genes, myc | 5 | 2.0 |
Evolution | 5 | 1.0 |
Bile Acids and Salts/*pharmacology | 2 | 11.0 |
Cholic Acids/pharmacology | 2 | 15.0 |
Deoxycholic Acid/pharmacology | 2 | 15.0 |
Epidermis/metabolism | 2 | 5.0 |
*Genome | 3 | 2.0 |
DNA, Viral/*genetics | 2 | 2.0 |
KB Cells | 2 | 2.0 |
RNA, Messenger/analysis/biosynthesis | 6 | 2.0 |
Gene Expression Regulation, Neoplastic/*genetics | 6 | 3.0 |
Thiazolidinediones/pharmacology | 2 | 12.0 |
Gene Expression Regulation, Leukemic | 2 | 2.0 |
Liver/physiology | 3 | 5.0 |
Ethers, Cyclic/pharmacology | 2 | 5.0 |
Okadaic Acid | 3 | 6.0 |
Repressor Proteins/*chemistry | 2 | 13.0 |
Immunoglobulins, kappa-Chain/*genetics | 2 | 9.0 |
Urinary Plasminogen Activator/biosynthesis/*genetics | 2 | 100.0 |
HIV-1/*genetics/*metabolism | 2 | 13.0 |
Folic Acid Antagonists/pharmacology | 2 | 11.0 |
Tetrahydrofolate Dehydrogenase/biosynthesis/*genetics | 2 | 50.0 |
Fetal Hemoglobin/*biosynthesis/genetics | 2 | 50.0 |
Genes, Switch | 2 | 18.0 |
Globins/*biosynthesis/*genetics | 2 | 100.0 |
HIV Enhancer/*genetics | 2 | 66.0 |
Poly A/metabolism | 2 | 4.0 |
Chloramphenicol O-Acetyltransferase/analysis/biosynthesis | 6 | 42.0 |
Ribonucleotide Reductases/*genetics | 2 | 28.0 |
alpha-Galactosidase/*genetics | 3 | 42.0 |
RNA, Neoplasm/genetics | 3 | 0.0 |
Alkaloids/pharmacology | 2 | 1.0 |
Fibroblasts/drug effects/metabolism | 3 | 2.0 |
Isoquinolines/pharmacology | 2 | 1.0 |
Staurosporine | 2 | 2.0 |
Tumor Necrosis Factor-alpha/*pharmacology | 8 | 0.0 |
Endothelium, Vascular/drug effects/*metabolism | 3 | 3.0 |
Gene Expression/*drug effects | 4 | 1.0 |
Transcription Factors/biosynthesis/*genetics/metabolism | 2 | 22.0 |
Viral Proteins/metabolism | 3 | 4.0 |
Cloning, Molecular/methods | 4 | 2.0 |
Chromosomes, Mammalian/genetics | 2 | 14.0 |
Membrane Proteins/genetics/metabolism | 2 | 1.0 |
Pedigree | 5 | 0.0 |
Neurons/*enzymology | 3 | 4.0 |
Nuclear Proteins/isolation & purification/metabolism | 4 | 30.0 |
Testicular Neoplasms/pathology | 2 | 28.0 |
Cell-Free System | 8 | 2.0 |
Cytochrome-B(5) Reductase | 2 | 18.0 |
Hominidae/*genetics | 9 | 5.0 |
Chemotactic Factors/*genetics | 2 | 14.0 |
T-Lymphocytes/drug effects/metabolism | 2 | 5.0 |
Fibronectins/*genetics | 2 | 6.0 |
Rats, Inbred F344 | 2 | 0.0 |
Chromosomes, Human, Pair 18 | 2 | 1.0 |
Chromosomes, Human, Pair 9 | 2 | 1.0 |
DNA, Neoplasm/genetics/isolation & purification | 3 | 2.0 |
Receptor, Insulin/*biosynthesis/*genetics | 2 | 100.0 |
Placenta/physiology | 5 | 14.0 |
Pregnancy-Specific beta 1-Glycoproteins/*genetics | 9 | 75.0 |
Trophoblasts/metabolism | 6 | 16.0 |
Carcinoembryonic Antigen/*genetics | 2 | 22.0 |
*Gestational Age | 8 | 13.0 |
Antigens, Viral/genetics | 2 | 11.0 |
HIV Long Terminal Repeat/*drug effects | 2 | 25.0 |
Amino Acid Oxidoreductases/*genetics | 2 | 12.0 |
Nitric-Oxide Synthase | 3 | 8.0 |
Pregnancy Tests | 4 | 40.0 |
Cytomegalovirus/genetics | 2 | 2.0 |
Neoplasm Proteins/metabolism | 4 | 1.0 |
Gene Products, tat/*genetics | 3 | 7.0 |
Amyloid beta-Protein Precursor/*genetics | 3 | 4.0 |
Cell Survival | 6 | 0.0 |
Calibration | 2 | 1.0 |
Reference Standards | 5 | 2.0 |
Reproducibility of Results | 3 | 0.0 |
World Health Organization | 3 | 3.0 |
Receptors, Dopamine/*genetics | 2 | 2.0 |
Proto-Oncogene Proteins c-raf | 2 | 1.0 |
Protein Kinase C/*genetics/metabolism | 2 | 25.0 |
Cervix Neoplasms | 2 | 8.0 |
Zinc/pharmacology | 4 | 6.0 |
Gene Expression Regulation, Viral/drug effects | 2 | 9.0 |
5-Methylcytosine | 2 | 9.0 |
Leukemia, Myeloid/*genetics | 2 | 1.0 |
Action Potentials/physiology | 2 | 4.0 |
Bladder/innervation | 2 | 50.0 |
Neural Conduction/*physiology | 2 | 10.0 |
ATP-Binding Cassette Transporters/biosynthesis/*genetics | 2 | 18.0 |
Galanin | 2 | 5.0 |
Apolipoprotein A-I/*genetics | 2 | 6.0 |
Chromosomes, Human, Pair 22 | 2 | 1.0 |
Cytosine/*metabolism | 2 | 14.0 |
Cell Differentiation/genetics | 4 | 1.0 |
Fetal Blood/metabolism | 2 | 3.0 |
Receptors, Estrogen/biosynthesis/*metabolism | 2 | 50.0 |
RNA-Directed DNA Polymerase/metabolism | 2 | 2.0 |
DNA/analysis/chemistry/genetics | 2 | 20.0 |
Nuclear Proteins/analysis/*metabolism | 2 | 18.0 |
Receptor, Insulin/*genetics/metabolism | 5 | 55.0 |
alpha-Fetoproteins/*analysis | 11 | 2.0 |
Pyruvate Dehydrogenase Complex/*genetics | 2 | 14.0 |
Transcription Factors/chemistry/*physiology | 2 | 5.0 |
*Chromosomes, Human, Pair 19 | 2 | 0.0 |
DNA/isolation & purification | 5 | 3.0 |
Deoxyribonuclease I/diagnostic use | 2 | 20.0 |
Nucleotide Mapping | 11 | 25.0 |
Mice/genetics | 2 | 3.0 |
Gene Products, tat/*physiology | 2 | 5.0 |
Escherichia coli/genetics | 5 | 0.0 |
*Nerve Tissue Proteins | 2 | 0.0 |
Reoperation | 2 | 1.0 |
Linkage (Genetics) | 5 | 0.0 |
Tretinoin/metabolism | 2 | 5.0 |
Prognosis | 26 | 0.0 |
Bucladesine/pharmacology | 3 | 1.0 |
Aspartic Endopeptidases/*genetics | 4 | 23.0 |
Proprotein Convertases | 2 | 4.0 |
Chickens/genetics | 2 | 4.0 |
DNA/genetics/isolation & purification | 8 | 3.0 |
Tumor Markers, Biological/analysis | 2 | 0.0 |
*Cytosine | 2 | 9.0 |
Sequence Deletion/physiology | 3 | 27.0 |
Gene Products, tat/physiology | 3 | 17.0 |
Oncogene Proteins, Viral/*metabolism | 2 | 5.0 |
Isoenzymes/biosynthesis/genetics | 3 | 6.0 |
Pregnancy Complications/*blood | 10 | 28.0 |
*Trisomy | 2 | 1.0 |
Magnetic Resonance Imaging | 2 | 0.0 |
Genes, Tumor Suppressor | 3 | 0.0 |
Neoplasm Metastasis | 8 | 0.0 |
Chickens/*genetics | 2 | 2.0 |
Chromosomes, Artificial, Bacterial/genetics | 2 | 4.0 |
I-kappa B/metabolism | 4 | 5.0 |
Receptors, N-Methyl-D-Aspartate/*genetics | 2 | 8.0 |
DNA-Binding Proteins/*genetics/physiology | 2 | 2.0 |
Papillomavirus, Human/genetics/*metabolism | 2 | 22.0 |
RNA, Viral/biosynthesis | 2 | 4.0 |
HIV-1/*genetics/growth & development | 3 | 25.0 |
T-Lymphocytes/microbiology | 3 | 13.0 |
Placental Lactogen/*analysis | 5 | 100.0 |
O(6)-Methylguanine-DNA Methyltransferase | 2 | 1.0 |
Antigens, CD14 | 2 | 0.0 |
Endothelium, Vascular/cytology/*drug effects/metabolism | 2 | 2.0 |
History, 20th Century | 2 | 1.0 |
Portraits | 2 | 7.0 |
Sweden | 2 | 0.0 |
Epitopes | 3 | 0.0 |
*Chromosomes, Human, Pair 1 | 2 | 0.0 |
Retroviridae Proteins, Oncogenic/metabolism | 2 | 5.0 |
Simian virus 40/*genetics | 7 | 13.0 |
Placental Lactogen/*secretion | 2 | 50.0 |
Pregnancy-Specific beta 1-Glycoproteins/*secretion | 3 | 100.0 |
Mice, Inbred Strains/*genetics | 2 | 10.0 |
DNA, Viral/*genetics/metabolism | 2 | 28.0 |
Brain/*physiology | 2 | 1.0 |
*Brain Mapping | 2 | 4.0 |
Pain/physiopathology | 3 | 14.0 |
Reaction Time/physiology | 3 | 3.0 |
Cell Nucleus/drug effects/metabolism | 4 | 7.0 |
Muscles/*metabolism | 2 | 2.0 |
Oligonucleotides, Antisense | 2 | 2.0 |
Amniotic Fluid/*metabolism | 5 | 12.0 |
Biological Markers/analysis | 3 | 0.0 |
Muscle, Skeletal/metabolism | 2 | 1.0 |
Fibroblasts/*metabolism | 5 | 3.0 |
Muscles/*enzymology | 2 | 2.0 |
Nuclear Proteins/biosynthesis/*genetics | 2 | 5.0 |
RNA, Messenger/biosynthesis/metabolism | 3 | 6.0 |
*Radiation Tolerance | 2 | 3.0 |
Virus Integration/genetics | 2 | 18.0 |
Muscles/metabolism | 3 | 3.0 |
Mutation, Missense | 3 | 0.0 |
Protein Denaturation | 2 | 0.0 |
Saccharomyces cerevisiae | 2 | 0.0 |
DNA Restriction Enzymes | 7 | 1.0 |
Nerve Tissue Proteins/*metabolism | 2 | 0.0 |
Codon/genetics | 2 | 0.0 |
Carrier Proteins/*biosynthesis/*genetics | 3 | 12.0 |
Folic Acid/metabolism | 2 | 5.0 |
Oncogenes | 2 | 0.0 |
Oncogene Proteins, Viral/genetics | 2 | 5.0 |
Repetitive Sequences, Nucleic Acid/genetics | 2 | 2.0 |
Abortion, Spontaneous | 6 | 22.0 |
Estriol/blood | 6 | 18.0 |
Maternal Age | 2 | 2.0 |
HIV/*genetics/growth & development | 2 | 50.0 |
Neuroblastoma/*genetics/pathology | 2 | 6.0 |
Methotrexate/pharmacology | 2 | 2.0 |
Chorionic Gonadotropin/*blood | 31 | 31.0 |
Estriol/*blood | 6 | 16.0 |
DNA-Binding Proteins/biosynthesis/*genetics | 2 | 1.0 |
Larva | 2 | 6.0 |
Placental Lactogen/blood | 15 | 60.0 |
Pregnancy Proteins/*biosynthesis | 11 | 64.0 |
Pregnancy-Associated Plasma Protein-A/metabolism | 5 | 83.0 |
alpha-Fetoproteins/metabolism | 6 | 6.0 |
Herpesvirus 1, Human/*genetics | 2 | 7.0 |
Nucleoproteins/metabolism | 2 | 28.0 |
*Guanine | 2 | 12.0 |
Poly A/genetics | 2 | 4.0 |
Stomach Neoplasms/*metabolism/pathology | 2 | 3.0 |
alpha-Fetoproteins/*metabolism | 3 | 2.0 |
Erythropoiesis | 2 | 2.0 |
Globins/genetics | 3 | 2.0 |
Fructose-Bisphosphate Aldolase/*genetics | 3 | 33.0 |
*Receptors, Retinoic Acid | 2 | 14.0 |
Receptors, Thyroid Hormone/*metabolism | 2 | 5.0 |
Chromatography, Gel | 6 | 0.0 |
Chromatography, Ion Exchange | 6 | 1.0 |
Adenoviruses, Human/*genetics | 3 | 1.0 |
Virion/metabolism | 2 | 5.0 |
Estrogens/*urine | 2 | 28.0 |
Pregnancy/*metabolism | 6 | 10.0 |
Poly A/*genetics | 2 | 14.0 |
RNA, Viral/genetics | 2 | 2.0 |
DNA/genetics/*metabolism | 3 | 4.0 |
Fetal Hemoglobin/*genetics | 3 | 30.0 |
Protein Disulfide-Isomerase | 2 | 10.0 |
Osteocalcin/genetics | 2 | 8.0 |
Up-Regulation/physiology | 2 | 1.0 |
CA-15-3 Antigen | 3 | 3.0 |
Luteinizing Hormone/blood | 3 | 0.0 |
DNA/*analysis | 2 | 0.0 |
DNA/*genetics/isolation & purification | 2 | 3.0 |
Antigens, CD11 | 3 | 3.0 |
Brain Neoplasms/*pathology | 2 | 2.0 |
Histocytochemistry | 13 | 1.0 |
Ultrafiltration | 2 | 3.0 |
DNA-Binding Proteins/isolation & purification/metabolism | 2 | 18.0 |
*Receptors, Chemokine | 2 | 2.0 |
alpha-Mannosidase | 2 | 20.0 |
Poly A/genetics/isolation & purification | 2 | 5.0 |
Cell Nucleus/physiology | 3 | 4.0 |
RNA, Neoplasm/genetics/isolation & purification | 2 | 3.0 |
Papillomavirus/*genetics | 3 | 16.0 |
Steroid 21-Hydroxylase/*genetics | 2 | 3.0 |
Antigens, Viral/*genetics | 2 | 11.0 |
Gene Expression Regulation, Enzymologic/physiology | 2 | 2.0 |
Pregnancy Proteins/*metabolism | 24 | 43.0 |
Macaca fascicularis | 7 | 2.0 |
Pregnancy Proteins/*analysis | 123 | 90.0 |
DNA-Binding Protein, Cyclic AMP-Responsive | 2 | 8.0 |
DNA Fingerprinting | 6 | 5.0 |
Platelet Membrane Glycoproteins/*genetics | 2 | 6.0 |
Proto-Oncogene Proteins/genetics | 3 | 0.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/genetics/metabolism | 2 | 13.0 |
Fetal Growth Retardation/*blood | 4 | 26.0 |
Pre-Eclampsia/*blood | 2 | 4.0 |
Pregnancy-Specific beta 1-Glycoproteins/metabolism | 15 | 100.0 |
Immunoassay/*methods | 3 | 3.0 |
Chromosome Deletion | 14 | 2.0 |
RNA/biosynthesis | 2 | 2.0 |
Teratoma | 2 | 14.0 |
Chorionic Gonadotropin/*secretion | 2 | 14.0 |
Organ Culture Techniques | 2 | 0.0 |
Longitudinal Studies | 2 | 0.0 |
Osteoporosis, Postmenopausal/genetics | 2 | 25.0 |
*Sequence Homology, Nucleic Acid | 2 | 2.0 |
Adenoviridae/*genetics | 2 | 0.0 |
Adenovirus Early Proteins | 6 | 8.0 |
Gene Expression Regulation, Viral/physiology | 2 | 8.0 |
Eukaryotic Cells/*metabolism | 3 | 6.0 |
Molecular Biology | 2 | 0.0 |
Receptors, Estrogen/*genetics/metabolism | 2 | 8.0 |
*Menstruation | 2 | 5.0 |
Anoxia | 3 | 3.0 |
Growth Hormone/*genetics | 4 | 11.0 |
Chorionic Gonadotropin/metabolism | 8 | 25.0 |
Chorionic Gonadotropin, beta Subunit, Human | 17 | 38.0 |
Pregnancy Complications/*metabolism | 2 | 50.0 |
Prolactin/metabolism | 2 | 3.0 |
Choriocarcinoma/blood | 5 | 38.0 |
Hydatidiform Mole/*blood | 4 | 57.0 |
Peptide Fragments/*blood | 8 | 9.0 |
Tumor Markers, Biological/blood | 2 | 1.0 |
Uterine Neoplasms/*blood | 12 | 57.0 |
Receptors, Erythropoietin | 3 | 12.0 |
Erythropoietin/metabolism | 2 | 8.0 |
Recombinant Proteins/isolation & purification/metabolism | 2 | 1.0 |
RNA, Small Interfering/genetics/metabolism | 2 | 4.0 |
Transcription Factors/deficiency/genetics/*metabolism | 2 | 13.0 |
Plicamycin/metabolism/*pharmacology | 2 | 100.0 |
Neoplasm Transplantation | 5 | 0.0 |
Pregnancy-Specific beta 1-Glycoproteins/biosynthesis | 4 | 100.0 |
alpha-Fetoproteins/biosynthesis | 2 | 16.0 |
Lung Neoplasms/*blood | 4 | 18.0 |
Homeodomain Proteins/genetics/metabolism | 2 | 2.0 |
Autoradiography | 2 | 0.0 |
Cell Separation | 2 | 0.0 |
Apgar Score | 2 | 8.0 |
Estrogens/urine | 2 | 28.0 |
Fetal Diseases/*diagnosis | 3 | 7.0 |
Prenatal Diagnosis/methods | 2 | 6.0 |
RNA Polymerase II/*physiology | 2 | 33.0 |
Pregnancy, Ectopic/*metabolism | 2 | 100.0 |
RNA, Messenger/genetics/isolation & purification | 2 | 3.0 |
Electrophoresis, Agar Gel | 4 | 0.0 |
B-Lymphocytes/*immunology | 2 | 0.0 |
Down-Regulation/drug effects | 4 | 1.0 |
Transcription Factor, Sp1/genetics/isolation & purification/*metabolism | 2 | 100.0 |
Fluorescent Antibody Technique | 11 | 0.0 |
Tumor Cells, Cultured/metabolism | 3 | 1.0 |
*Placental Function Tests | 4 | 80.0 |
Pregnancy in Diabetics/*blood | 2 | 5.0 |
Ferritin/blood | 2 | 1.0 |
Collagen Type I/*genetics/metabolism | 2 | 40.0 |
Dermis/cytology | 2 | 15.0 |
Neoplasms/*blood | 4 | 9.0 |
Cytosol/*enzymology | 2 | 3.0 |
Hemoglobinopathies/*genetics | 3 | 50.0 |
Fetal Growth Retardation/*diagnosis | 4 | 50.0 |
Leukemia, Myeloid | 2 | 5.0 |
*Genes, Dominant | 2 | 0.0 |
Fibroblasts/*drug effects/physiology | 2 | 25.0 |
Hepatocytes/*metabolism | 3 | 7.0 |
Ornithine-Oxo-Acid Transaminase/*genetics | 2 | 8.0 |
Transaminases/*genetics | 2 | 6.0 |
Saccharomyces cerevisiae/metabolism | 2 | 1.0 |
Tumor Cells, Cultured/enzymology | 2 | 5.0 |
Alkaline Phosphatase/analysis | 4 | 7.0 |
Cross Reactions | 3 | 0.0 |
Placenta/*analysis | 7 | 26.0 |
Abortion, Threatened/*blood | 4 | 57.0 |
Hydatidiform Mole/blood | 3 | 100.0 |
alpha 1-Antitrypsin/analysis | 2 | 2.0 |
Endothelium, Vascular/*cytology | 2 | 1.0 |
Amino Acids/analysis | 3 | 1.0 |
Placenta/analysis | 9 | 40.0 |
Pregnancy Proteins/*isolation & purification | 5 | 83.0 |
Pregnancy-Specific beta 1-Glycoproteins/*biosynthesis | 10 | 100.0 |
Amino Acid Sequence/genetics | 2 | 0.0 |
Transforming Growth Factor beta/physiology | 2 | 2.0 |
*Antibodies, Monoclonal | 2 | 0.0 |
Antigens, Neoplasm/analysis | 4 | 1.0 |
Carcinoembryonic Antigen/analysis | 7 | 6.0 |
Keratin/analysis | 2 | 0.0 |
Decidua/analysis | 2 | 66.0 |
Trophoblasts/analysis | 3 | 100.0 |
*Abortion, Induced | 4 | 18.0 |
Oncogene Proteins, Viral/*physiology | 2 | 5.0 |
Proto-Oncogene Proteins c-fos | 2 | 3.0 |
*Ultrasonography | 3 | 9.0 |
Uterus/pathology | 2 | 28.0 |
Pregnancy/*immunology | 2 | 3.0 |
Pregnancy Trimester, Third | 26 | 13.0 |
DNA-Binding Proteins/*analysis | 2 | 3.0 |
Receptors, Thyroid Hormone/genetics/metabolism | 2 | 22.0 |
Ultrasonography | 7 | 8.0 |
*Blood Stains | 2 | 5.0 |
*Pregnancy Tests | 2 | 66.0 |
Pregnancy-Specific beta 1-Glycoproteins/*blood | 22 | 95.0 |
*Placenta | 3 | 42.0 |
Amnion/cytology/*metabolism | 2 | 33.0 |
Antimetabolites/*pharmacology | 2 | 14.0 |
Antigens, Neoplasm/*analysis | 5 | 1.0 |
Trophoblastic Neoplasms/*blood | 8 | 88.0 |
Transcription Factors/*isolation & purification/metabolism | 2 | 28.0 |
Antigens, Polyomavirus Transforming/genetics | 2 | 6.0 |
BK Virus/*genetics | 2 | 22.0 |
Polyomavirus/*genetics | 2 | 40.0 |
*Motor Vehicles | 2 | 8.0 |
Myocardial Infarction/*etiology | 2 | 6.0 |
Patient Transfer | 2 | 8.0 |
*Transportation of Patients | 2 | 8.0 |
Vehicle Emissions/*adverse effects | 2 | 6.0 |
Internet | 3 | 3.0 |
NF-kappa B/*antagonists & inhibitors/metabolism | 2 | 8.0 |
*Conflict of Interest | 2 | 10.0 |
*Drug Industry | 2 | 9.0 |
Ethics, Professional | 2 | 10.0 |
Physicians/economics/ethics | 2 | 10.0 |
Registries/*statistics & numerical data | 2 | 6.0 |
Transcription Factors/analysis | 2 | 2.0 |
Placental Lactogen/analysis | 11 | 84.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 3 | 0.0 |
Pregnancy, Tubal/*metabolism | 2 | 66.0 |
Chorionic Gonadotropin/urine | 2 | 50.0 |
Tumor Cells, Cultured/pathology | 2 | 3.0 |
Trypsin/metabolism | 2 | 1.0 |
DNA/*genetics/metabolism | 2 | 10.0 |
Choriocarcinoma/*pathology | 2 | 40.0 |
Uterine Neoplasms/*pathology | 3 | 13.0 |
Immunochemistry | 5 | 2.0 |
Abortion, Spontaneous/diagnosis | 2 | 100.0 |
*Insulin-Like Growth Factor Binding Proteins | 7 | 58.0 |
Pregnancy Proteins/*analysis/*blood | 2 | 100.0 |
Reagent Kits, Diagnostic | 2 | 1.0 |
*Intracellular Signaling Peptides and Proteins | 2 | 0.0 |
Neoplasm Proteins/*blood | 4 | 7.0 |
*Labor, Obstetric | 2 | 8.0 |
Ovarian Neoplasms/*blood | 2 | 15.0 |
Peptides/analysis | 2 | 2.0 |
Tissue Polypeptide Antigen | 2 | 7.0 |
Pregnancy-Specific beta 1-Glycoproteins/blood | 4 | 100.0 |
Apoptosis/physiology | 2 | 0.0 |
Immunoassay | 3 | 1.0 |
Chorionic Villi/analysis | 2 | 66.0 |
Hela Cells/analysis | 2 | 18.0 |
Interferon-alpha/pharmacology | 2 | 2.0 |
Birth Weight | 6 | 3.0 |
Trophoblasts/cytology/*immunology/metabolism | 2 | 66.0 |
Pregnancy Tests/*methods | 4 | 80.0 |
Radioimmunoassay/*methods | 6 | 8.0 |
*Gamma Rays | 2 | 4.0 |
Amniotic Fluid/*analysis | 6 | 8.0 |
Trophoblasts/*analysis/cytology | 2 | 100.0 |
Pregnancy, Ectopic/*blood | 2 | 40.0 |
Lung Neoplasms/secondary | 2 | 2.0 |
Pregnancy Proteins/*cerebrospinal fluid | 2 | 100.0 |
Pregnancy-Specific beta 1-Glycoproteins/*cerebrospinal fluid | 2 | 100.0 |
Trophoblastic Neoplasms/*blood/diagnosis | 2 | 100.0 |
Uterine Neoplasms/*blood/diagnosis | 2 | 100.0 |
Triticum | 2 | 25.0 |
Peptide Fragments/blood | 2 | 1.0 |
Immunoassay/methods | 2 | 3.0 |
Immunoglobulin A/analysis | 2 | 1.0 |
Immunoglobulin G/analysis | 3 | 0.0 |
Immunoglobulin M/analysis | 3 | 1.0 |
Multiple Myeloma/blood | 2 | 13.0 |
Paraproteinemias/*blood | 2 | 25.0 |
Waldenstrom Macroglobulinemia/blood | 2 | 40.0 |
DNA-Binding Proteins/*isolation & purification/metabolism | 2 | 22.0 |
Glioma/metabolism | 2 | 16.0 |
Fetal Growth Retardation/*blood/diagnosis | 2 | 50.0 |
Fetal Growth Retardation/blood | 4 | 33.0 |
Hypertension/*blood | 4 | 6.0 |
Pregnancy Complications, Cardiovascular/*blood | 5 | 23.0 |
Labor, Obstetric | 2 | 4.0 |
Macaca mulatta | 3 | 0.0 |
Guanidine | 2 | 7.0 |
*Pregnancy Proteins | 4 | 44.0 |
*Pregnancy-Specific beta 1-Glycoproteins | 4 | 57.0 |
Immunoelectrophoresis | 13 | 5.0 |
*Pregnancy | 32 | 23.0 |
Monitoring, Physiologic | 3 | 3.0 |
Prolactin/blood | 2 | 0.0 |
*Immunoenzyme Techniques | 2 | 1.0 |
Testicular Neoplasms/*blood | 2 | 22.0 |
Immune Sera/isolation & purification | 2 | 25.0 |
Immunodiffusion | 11 | 4.0 |
Carcinoma, Bronchogenic/*blood | 3 | 75.0 |
Pregnancy Proteins/*secretion | 3 | 100.0 |
Pre-Eclampsia/blood | 4 | 22.0 |
Fetal Growth Retardation/diagnosis | 2 | 28.0 |
Pregnancy Proteins/*immunology | 3 | 50.0 |
Pregnancy-Specific beta 1-Glycoproteins/*immunology | 2 | 100.0 |
Decidua/metabolism | 2 | 7.0 |
Endometrium/metabolism | 3 | 5.0 |
Pregnancy-Associated Plasma Protein-A/*metabolism | 5 | 71.0 |
Pregnancy-Specific beta 1-Glycoproteins/analysis/*blood | 2 | 100.0 |
Antigen-Antibody Complex | 2 | 1.0 |
Abortion, Threatened/diagnosis | 2 | 100.0 |
Pregnancy Proteins/analysis/*blood | 2 | 100.0 |
T-Lymphocytes/*virology | 2 | 3.0 |
False Negative Reactions | 2 | 1.0 |
Microchemistry | 3 | 9.0 |
Trophoblasts/*immunology | 2 | 6.0 |
Pregnancy Complications/blood | 2 | 22.0 |
Antigens, Neoplasm/*immunology | 3 | 1.0 |
Carcinoembryonic Antigen/immunology | 2 | 14.0 |
Placenta/enzymology | 3 | 3.0 |
Testicular Neoplasms/*analysis | 2 | 33.0 |
*Delivery, Obstetric | 2 | 11.0 |
Organ Size | 5 | 2.0 |
*Pregnancy, Multiple | 2 | 15.0 |
Twins | 5 | 12.0 |
Ferritin/analysis | 3 | 16.0 |
Placental Lactogen/*metabolism | 3 | 60.0 |
Histone Deacetylases/*antagonists & inhibitors/metabolism | 2 | 13.0 |
*Reagent Kits, Diagnostic | 2 | 3.0 |
Blood Proteins/*analysis | 4 | 2.0 |
Transferrin/analysis | 3 | 3.0 |
Immunoelectrophoresis, Two-Dimensional | 12 | 9.0 |
Radioimmunoassay/methods | 7 | 4.0 |
Beta-Globulins/*analysis | 5 | 12.0 |
Abnormalities, Multiple/diagnosis | 2 | 33.0 |
Abortion, Threatened/*diagnosis | 3 | 100.0 |
Nephelometry and Turbidimetry | 4 | 5.0 |
Circadian Rhythm | 2 | 0.0 |
Amnion/cytology/physiology/*transplantation | 2 | 100.0 |
Chorionic Gonadotropin/biosynthesis | 2 | 28.0 |
Mucous Membrane/cytology | 2 | 18.0 |
Pituitary Hormone-Releasing Hormones/biosynthesis | 2 | 66.0 |
Placenta/cytology/physiology/*transplantation | 2 | 100.0 |
Pregnancy Proteins/biosynthesis | 2 | 33.0 |
*Transplantation, Heterologous | 2 | 2.0 |
Vagina/cytology | 2 | 100.0 |
alpha-Macroglobulins/*analysis | 2 | 9.0 |
Neoplasms/blood | 3 | 8.0 |
Choriocarcinoma/immunology | 2 | 50.0 |
Mesonephroma/immunology | 2 | 100.0 |
Teratoma/immunology | 2 | 40.0 |
Adsorption | 2 | 1.0 |
*Postpartum Period | 2 | 5.0 |
Pregnancy-Specific beta 1-Glycoproteins/*analysis/cerebrospinal fluid | 2 | 100.0 |
Neuraminidase/pharmacology | 2 | 2.0 |
Glycoproteins/blood | 7 | 12.0 |
Uterine Hemorrhage/diagnosis | 2 | 100.0 |
Dysgerminoma/blood | 2 | 22.0 |
Teratoma/blood | 3 | 17.0 |
Carbohydrates/analysis | 2 | 3.0 |
Placenta | 3 | 7.0 |
Insulin/therapeutic use | 2 | 1.0 |
Peptide Fragments/analysis | 2 | 0.0 |
DNA-Binding Proteins/genetics/metabolism/physiology | 2 | 14.0 |
Polyethylene Glycols/pharmacology | 2 | 4.0 |
Precipitation | 5 | 3.0 |
Pregnancy-Specific beta 1-Glycoproteins/*isolation & purification | 4 | 100.0 |
Choriocarcinoma/*blood | 4 | 80.0 |
Pregnancy-Specific beta 1-Glycoproteins/*analysis/immunology | 2 | 100.0 |
Amniotic Fluid/analysis | 2 | 4.0 |
Nephelometry and Turbidimetry/methods | 2 | 28.0 |
Adenocarcinoma/immunology | 2 | 4.0 |
Intestines/pathology | 2 | 11.0 |
Cervix Neoplasms/blood | 2 | 22.0 |
Fetal Blood/analysis | 3 | 5.0 |
Uterine Neoplasms/blood | 2 | 28.0 |
Hydatidiform Mole/diagnosis | 2 | 50.0 |
Pregnancy-Specific beta 1-Glycoproteins/*analysis/blood | 2 | 100.0 |
Pregnancy Proteins/*urine | 2 | 66.0 |
Fluoresceins | 2 | 3.0 |
Immune Sera | 2 | 0.0 |
Trophoblasts/*metabolism | 2 | 4.0 |
Pregnancy Complications/*diagnosis | 2 | 18.0 |
Placenta Diseases/*diagnosis | 3 | 100.0 |
Breast Neoplasms/*blood | 2 | 4.0 |
Chorionic Gonadotropin/secretion | 2 | 15.0 |
Immunoelectrophoresis/methods | 2 | 20.0 |
Breast Neoplasms/metabolism | 2 | 1.0 |
HT29 Cells | 2 | 1.0 |
Glycoproteins/*immunology | 3 | 3.0 |
Parity | 2 | 1.0 |
Fibroblasts/cytology/physiology | 2 | 2.0 |
GC Rich Sequence/physiology | 2 | 66.0 |
Immunoglobulin G/blood | 2 | 0.0 |
Cyclic AMP-Dependent Protein Kinases/metabolism | 3 | 1.0 |
Homeostasis | 2 | 0.0 |
Cross-Linking Reagents/pharmacology | 2 | 1.0 |
Cisplatin/pharmacology | 2 | 1.0 |
